If you've thought it, someone else has asked it. Find your answers here — and if yours isn't on the list, we're one message away.
Before your appointment, all patients are required to register through our Symplast Patient App and complete their Medical History Questionnaire and all required consent forms at least 72 hours prior to their scheduled appointment. This allows Erica Granteed, AGACNP-BC, adequate time to thoroughly review your medical history, assess relevant information, and prepare for your consultation.
Failure to complete the required documentation within the designated timeframe may result in cancellation of your appointment and forfeiture of your consultation fee.
We also ask that you arrive on time and fully prepared for your appointment. Time spent completing outstanding paperwork or arriving late will not extend your scheduled appointment. Your consultation will still conclude at its originally scheduled time, regardless of when you are ready to begin.
We respect every patient’s time and are committed to maintaining our appointment schedule. Extending one appointment would delay care for the patients scheduled afterward, which is why we are unable to accommodate additional time for late arrivals or incomplete paperwork.
We appreciate your cooperation in completing all requirements in advance so that your entire appointment can be dedicated to addressing your concerns, discussing your goals, and providing the personalized care you deserve.
For virtual consultations, please ensure you are in a quiet, private, and comfortable location with a reliable internet connection. You should be somewhere you feel comfortable openly discussing your concerns, medical history, and treatment goals.
As part of your consultation, Erica will also need to perform a brief visual assessment of your anatomy to evaluate your candidacy, discuss realistic expectations, and determine the most appropriate treatment recommendations. Please plan accordingly and ensure you have sufficient privacy to comfortably participate in this portion of your appointment.
Without an appropriate anatomical assessment, Erica may be unable to provide individualized treatment recommendations or accurate cost estimates. If the assessment cannot be completed during your scheduled consultation, an additional appointment may be required, which may involve an additional consultation fee.
Our goal is to make your consultation as comfortable, informative, and productive as possible while ensuring you receive an accurate, personalized evaluation.
Yes. All consultations are scheduled appointments dedicated to providing individualized medical guidance and professional recommendations.
Our consultation options include:
Your consultation fee covers the dedicated time, clinical expertise, individualized assessment, patient education, and professional recommendations provided by Erica Granteed, AGACNP-BC.
Consultations are medical appointments, not simply conversations about pricing or services. Each appointment involves a personalized evaluation to determine whether a treatment is medically appropriate, safe, and aligned with your goals and realistic expectations.
All consultation fees are collected at the time of scheduling and are non-refundable. The fee compensates the provider for her time and professional expertise, regardless of whether you ultimately choose to proceed with treatment or are determined to be an appropriate candidate.
Please note: Payment for a consultation does not guarantee treatment eligibility, approval for a specific procedure, or any particular outcome. All treatment recommendations are based on clinical judgment, patient safety, and individual medical considerations.
Wonderful! Simply contact our office and let our team know you’re ready to move forward.
We will review appointment availability, discuss any required scheduling fees, and coordinate your treatment appointment with Erica Granteed, AGACNP-BC.
Depending on your treatment plan, additional instructions, documentation, or pre-treatment requirements may be necessary. Our team will guide you through the process to ensure you’re fully prepared.
Not at all! We regularly welcome patients who travel from across the United States and internationally to receive treatment at The District Injector.
For patients traveling from outside the Northern Virginia area, we offer the convenience of beginning with a virtual consultation through our secure, HIPAA-compliant patient platform. This allows you to meet privately with Erica Granteed, AGACNP-BC, to discuss your medical history, concerns, treatment goals, and potential candidacy without the expense or inconvenience of traveling for an initial appointment.
Please keep in mind that virtual consultations may require a brief visual assessment of your anatomy to determine treatment eligibility and provide individualized recommendations and cost estimates.
Once you have completed your consultation and decide to move forward with treatment, our team will assist with coordinating your appointment and provide a travel brochure featuring helpful information about nearby airports, transportation, accommodations, and local hotel options.
For certain procedures, including male enhancement with HA filler, we recommend that patients remain in the local area for at least 48 hours following treatment. This allows time for initial recovery and provides an opportunity to address any immediate post-procedure concerns before traveling home.
Depending on your treatment and individual circumstances, follow-up appointments may also be conducted virtually.
Our goal is to make traveling for treatment as convenient, comfortable, and well-coordinated as possible while prioritizing your safety and continuity of care.
The District Injector
8180 Greensboro Drive, Suite 300
McLean, VA 22102
Our office is located on the third floor, and the parking garage elevator provides direct access to our floor.
Parking Options:
The District Injector is located in McLean, Virginia, and operates exclusively on Eastern Time (ET). All appointments, including virtual consultations, are scheduled according to our local time zone, regardless of where the patient resides or is physically located at the time of their appointment.
It is each patient’s responsibility to verify the time difference between their location and Eastern Time when scheduling an appointment. We strongly encourage patients traveling or joining virtually from other states or countries to confirm the correct appointment time in their respective time zones.
Please note: Misunderstanding, overlooking, or failing to account for time zone differences does not qualify as an exception to our scheduling, cancellation, or no-show policies. Appointments missed due to time zone confusion are considered missed appointments, and consultation fees will not be refunded, credited, or transferred for this reason.
We appreciate your understanding and encourage you to double-check your appointment confirmation to ensure you are available at the correct scheduled time.
Absolutely! We welcome patients from across the United States and beyond.
Many of our patients travel specifically for Erica’s experience in men’s aesthetic and sexual wellness treatments.
To make the process as convenient as possible, we offer virtual consultations for eligible patients and provide travel resources once a treatment plan has been established.
Our team is happy to help you understand the logistics of traveling for your procedure, including any recommended post-treatment observation or follow-up requirements.
Absolutely. At The District Injector, we understand that discussing personal, intimate, or sensitive health concerns requires a high level of trust, privacy, and discretion. We are committed to providing a professional, respectful, and judgment-free environment where every patient feels comfortable discussing their concerns openly and honestly.
All consultations, examinations, and treatments are conducted with the utmost professionalism and respect for your personal privacy. Your medical information, treatment history, photographs, and personal details are handled confidentially in accordance with applicable HIPAA privacy and security regulations.
We utilize secure patient communication systems and electronic medical records to safeguard your protected health information. Patient photographs, medical records, and treatment details are never shared publicly or used for marketing purposes without appropriate written authorization.
Whether you’re seeking treatment for aesthetic concerns, sexual wellness, or other personal health matters, you can expect the same level of discretion, professionalism, and individualized attention.
Your privacy matters to us, and our goal is to ensure you feel respected, comfortable, and confident throughout every step of your care.
Most patients find penile girth enhancement with hyaluronic acid (HA) filler to be a manageable and well-tolerated procedure. At The District Injector, we prioritize your comfort and take several steps to minimize discomfort throughout your treatment.
Before beginning, topical numbing cream is applied to the penis, followed by additional local anesthetic as appropriate to help minimize sensitivity during the procedure.
Erica Granteed, AGACNP-BC, utilizes a cannula-based injection technique, which allows filler to be carefully distributed beneath the penile skin while minimizing the number of entry points compared with multiple traditional needle injections.
You may experience a brief pinch during the initial anesthetic administration, followed by sensations of pressure, movement, or fullness as the filler is placed. While some discomfort is possible, the goal is to keep you as comfortable as possible throughout the procedure.
As the numbing medication wears off, you may experience mild to moderate tenderness, swelling, bruising, or sensitivity. These effects are generally temporary and typically improve over the following days, although swelling and healing can vary between patients.
Erica will provide detailed aftercare instructions to help manage discomfort, support proper healing, and minimize complications.
Our goal is to make your male enhancement experience as comfortable, discreet, and stress-free as possible. Throughout your appointment, Erica will explain each step, monitor your comfort, and ensure you feel informed and supported.
While discomfort is generally manageable, individual experiences vary, and no procedure can be guaranteed to be completely pain-free.
Yes! Patients who use Trimix injections for erectile dysfunction can generally continue their treatment following penile girth enhancement with hyaluronic acid (HA) filler.
However, it is important to allow adequate healing time following your enhancement procedure before resuming penile injections.
Because HA filler is placed within the tissues surrounding the penile shaft, proper injection technique is especially important. Trimix must be administered directly into the corpus cavernosum (erectile tissue), rather than into the filler or surrounding superficial tissues.
During your consultation, Erica Granteed, AGACNP-BC, will review your current Trimix regimen, discuss appropriate injection techniques, and provide individualized recommendations regarding when it is safe to resume treatment.
Please do not resume Trimix injections until you have been cleared to do so following your enhancement procedure. Injection sites and technique may need to be reassessed to avoid disturbing the filler, introducing infection, or causing other complications.
Our goal is to ensure you can continue managing your erectile health while protecting your enhancement results and supporting proper healing.
Before your appointment, all patients are required to register through our Symplast Patient App and complete their Medical History Questionnaire and all required consent forms at least 72 hours prior to their scheduled appointment. This allows Erica Granteed, AGACNP-BC, adequate time to thoroughly review your medical history, assess relevant information, and prepare for your consultation.
Failure to complete the required documentation within the designated timeframe may result in cancellation of your appointment and forfeiture of your consultation fee.
We also ask that you arrive on time and fully prepared for your appointment. Time spent completing outstanding paperwork or arriving late will not extend your scheduled appointment. Your consultation will still conclude at its originally scheduled time, regardless of when you are ready to begin.
We respect every patient’s time and are committed to maintaining our appointment schedule. Extending one appointment would delay care for the patients scheduled afterward, which is why we are unable to accommodate additional time for late arrivals or incomplete paperwork.
We appreciate your cooperation in completing all requirements in advance so that your entire appointment can be dedicated to addressing your concerns, discussing your goals, and providing the personalized care you deserve.
CockTox is a non-surgical penile enhancement treatment that involves injecting botulinum toxin (commonly known as Botox) into targeted areas of the penis to help relax smooth muscle and potentially improve flaccid penile hang and appearance.
By reducing smooth muscle contraction, CockTox may allow the penis to appear more relaxed, fuller, and less retracted when flaccid.
Unlike hyaluronic acid (HA) filler, CockTox does not physically add volume or increase penile girth. Instead, its intended effect is to improve the natural resting appearance of the penis through muscle relaxation.
Potential benefits include:
CockTox is an off-label use of botulinum toxin, and clinical research regarding its effectiveness for cosmetic penile enhancement remains limited. Results are not guaranteed, and potential risks include bruising, discomfort, infection, and unintended effects on erectile function.
CockTox does not permanently increase penile length or girth. Patients seeking additional girth may benefit from discussing HA filler as a separate or complementary treatment option.
CockTox is a minimally invasive treatment with little to no downtime, allowing most patients to return to their normal daily activities immediately following their appointment.
Patients may experience mild swelling, tenderness, redness, or bruising at the injection sites, which typically resolves within a few days.
Post-Treatment Recommendations:
For virtual consultations, please ensure you are in a quiet, private, and comfortable location with a reliable internet connection. You should be somewhere you feel comfortable openly discussing your concerns, medical history, and treatment goals.
As part of your consultation, Erica will also need to perform a brief visual assessment of your anatomy to evaluate your candidacy, discuss realistic expectations, and determine the most appropriate treatment recommendations. Please plan accordingly and ensure you have sufficient privacy to comfortably participate in this portion of your appointment.
Without an appropriate anatomical assessment, Erica may be unable to provide individualized treatment recommendations or accurate cost estimates. If the assessment cannot be completed during your scheduled consultation, an additional appointment may be required, which may involve an additional consultation fee.
Our goal is to make your consultation as comfortable, informative, and productive as possible while ensuring you receive an accurate, personalized evaluation.
Yes. All consultations are scheduled appointments dedicated to providing individualized medical guidance and professional recommendations.
Our consultation options include:
Your consultation fee covers the dedicated time, clinical expertise, individualized assessment, patient education, and professional recommendations provided by Erica Granteed, AGACNP-BC.
Consultations are medical appointments, not simply conversations about pricing or services. Each appointment involves a personalized evaluation to determine whether a treatment is medically appropriate, safe, and aligned with your goals and realistic expectations.
All consultation fees are collected at the time of scheduling and are non-refundable. The fee compensates the provider for her time and professional expertise, regardless of whether you ultimately choose to proceed with treatment or are determined to be an appropriate candidate.
Please note: Payment for a consultation does not guarantee treatment eligibility, approval for a specific procedure, or any particular outcome. All treatment recommendations are based on clinical judgment, patient safety, and individual medical considerations.
Wonderful! Simply contact our office and let our team know you’re ready to move forward or utilize our online booking link to schedule Cocktox.
We will review appointment availability, discuss any required scheduling fees, and coordinate your treatment appointment with Erica Granteed, AGACNP-BC.
Depending on your treatment plan, additional instructions, documentation, or pre-treatment requirements may be necessary. Our team will guide you through the process to ensure you’re fully prepared.
Not at all! We regularly welcome patients who travel from across the United States and internationally to receive treatment at The District Injector.
For patients traveling from outside the Northern Virginia area, we offer the convenience of beginning with a virtual consultation through our secure, HIPAA-compliant patient platform. This allows you to meet privately with Erica Granteed, AGACNP-BC, to discuss your medical history, concerns, treatment goals, and potential candidacy without the expense or inconvenience of traveling for an initial appointment.
Please keep in mind that virtual consultations may require a brief visual assessment of your anatomy to determine treatment eligibility and provide individualized recommendations and cost estimates.
Once you have completed your consultation and decide to move forward with treatment, our team will assist with coordinating your appointment and provide a travel brochure featuring helpful information about nearby airports, transportation, accommodations, and local hotel options.
For certain procedures, including male enhancement with HA filler, we recommend that patients remain in the local area for at least 48 hours following treatment. This allows time for initial recovery and provides an opportunity to address any immediate post-procedure concerns before traveling home.
Depending on your treatment and individual circumstances, follow-up appointments may also be conducted virtually.
Our goal is to make traveling for treatment as convenient, comfortable, and well-coordinated as possible while prioritizing your safety and continuity of care.
The District Injector
8180 Greensboro Drive, Suite 300
McLean, VA 22102
Our office is located on the third floor, and the parking garage elevator provides direct access to our floor.
Parking Options:
The District Injector is located in McLean, Virginia, and operates exclusively on Eastern Time (ET). All appointments, including virtual consultations, are scheduled according to our local time zone, regardless of where the patient resides or is physically located at the time of their appointment.
It is each patient’s responsibility to verify the time difference between their location and Eastern Time when scheduling an appointment. We strongly encourage patients traveling or joining virtually from other states or countries to confirm the correct appointment time in their respective time zones.
Please note: Misunderstanding, overlooking, or failing to account for time zone differences does not qualify as an exception to our scheduling, cancellation, or no-show policies. Appointments missed due to time zone confusion are considered missed appointments, and consultation fees will not be refunded, credited, or transferred for this reason.
We appreciate your understanding and encourage you to double-check your appointment confirmation to ensure you are available at the correct scheduled time.
Absolutely! We welcome patients from across the United States and beyond.
Many of our patients travel specifically for Erica’s experience in men’s aesthetic and sexual wellness treatments.
To make the process as convenient as possible, we offer virtual consultations for eligible patients and provide travel resources once a treatment plan has been established.
Our team is happy to help you understand the logistics of traveling for your procedure, including any recommended post-treatment observation or follow-up requirements.
Absolutely. At The District Injector, we understand that discussing personal, intimate, or sensitive health concerns requires a high level of trust, privacy, and discretion. We are committed to providing a professional, respectful, and judgment-free environment where every patient feels comfortable discussing their concerns openly and honestly.
All consultations, examinations, and treatments are conducted with the utmost professionalism and respect for your personal privacy. Your medical information, treatment history, photographs, and personal details are handled confidentially in accordance with applicable HIPAA privacy and security regulations.
We utilize secure patient communication systems and electronic medical records to safeguard your protected health information. Patient photographs, medical records, and treatment details are never shared publicly or used for marketing purposes without appropriate written authorization.
Whether you’re seeking treatment for aesthetic concerns, sexual wellness, or other personal health matters, you can expect the same level of discretion, professionalism, and individualized attention.
Your privacy matters to us, and our goal is to ensure you feel respected, comfortable, and confident throughout every step of your care.
CockTox may help improve erectile function in certain men experiencing erectile dysfunction (ED), although it is not currently an FDA-approved treatment for ED.
Initial pricing for CockTox starts at $1,200 for 100 units
Your CockTox appointment is designed to be comfortable, discreet, and efficient.
Upon arrival, clinical photographs will be taken for your confidential medical record to document your anatomy and establish a baseline for evaluating your results.
A topical numbing cream will then be applied to help minimize discomfort during treatment. Once the area is adequately numbed, the skin will be thoroughly cleansed and prepared for the procedure.
Erica Granteed, AGACNP-BC, will then carefully administer the CockTox injections into the targeted areas of the penis according to your individualized treatment plan and goals.
You can expect to be in our office for approximately 45–60 minutes, including clinical photography, numbing, preparation, treatment, and post-procedure instructions.
Most patients find CockTox to be a quick and tolerable procedure with minimal discomfort. We take several steps to help ensure your treatment experience is as comfortable as possible.
Before treatment, a topical numbing cream is applied to the penis to help reduce sensitivity at the injection sites. Once the area is adequately numbed, Erica Granteed, AGACNP-BC, will carefully administer the injections using a fine needle.
You may experience a brief pinch, pressure, or mild stinging sensation during the injections. Discomfort varies depending on individual sensitivity and the areas being treated. Topical numbing can reduce surface discomfort but may not eliminate sensations from deeper injections.
Following treatment, mild tenderness, swelling, or bruising may occur, typically resolving within a few days.
Our priority is to make your CockTox experience as comfortable, discreet, and stress-free as possible. Erica will explain each step of the procedure and ensure you feel informed and comfortable throughout your appointment.
Before your appointment, all patients are required to register through our Symplast Patient App and complete their Medical History Questionnaire and all required consent forms at least 72 hours prior to their scheduled appointment. This allows Erica Granteed, AGACNP-BC, adequate time to thoroughly review your medical history, assess relevant information, and prepare for your consultation.
Failure to complete the required documentation within the designated timeframe may result in cancellation of your appointment and forfeiture of your consultation fee.
We also ask that you arrive on time and fully prepared for your appointment. Time spent completing outstanding paperwork or arriving late will not extend your scheduled appointment. Your consultation will still conclude at its originally scheduled time, regardless of when you are ready to begin.
We respect every patient’s time and are committed to maintaining our appointment schedule. Extending one appointment would delay care for the patients scheduled afterward, which is why we are unable to accommodate additional time for late arrivals or incomplete paperwork.
We appreciate your cooperation in completing all requirements in advance so that your entire appointment can be dedicated to addressing your concerns, discussing your goals, and providing the personalized care you deserve.
ScroTox is a non-surgical aesthetic treatment that involves injecting botulinum toxin (commonly known as Botox) into the scrotal skin and underlying dartos muscle to promote relaxation, reduce tightness, and create a smoother, more relaxed appearance.
The dartos muscle naturally contracts in response to temperature, stimulation, and other factors, causing the scrotum to tighten and retract. By temporarily relaxing this muscle, ScroTox may allow the scrotum to hang lower and appear less wrinkled.
Results generally begin developing within several days, with the full effects typically appearing around 14-21 days.
Effects may last approximately 3–4 months, although individual results and duration vary.
ScroTox is an off-label use of botulinum toxin, meaning it is not specifically FDA-approved for scrotal enhancement. Clinical research on its cosmetic use in this area remains limited.
Potential side effects include temporary swelling, bruising, tenderness, asymmetry, and unintended muscle relaxation. Long-term safety and effects on testicular temperature and fertility have not been adequately established.
ScroTox does not physically enlarge the testicles or add volume to the scrotum. Instead, relaxation of the dartos muscle may allow the scrotal skin to hang more freely, creating the appearance of a fuller, lower-hanging scrotum.
ScroTox is a minimally invasive treatment with little to no downtime, allowing most patients to return to their normal daily activities immediately following their appointment.
Patients may experience mild swelling, tenderness, redness, or bruising at the injection sites, which typically resolves within a few days.
Post-Treatment Recommendations:
For virtual consultations, please ensure you are in a quiet, private, and comfortable location with a reliable internet connection. You should be somewhere you feel comfortable openly discussing your concerns, medical history, and treatment goals.
As part of your consultation, Erica will also need to perform a brief visual assessment of your anatomy to evaluate your candidacy, discuss realistic expectations, and determine the most appropriate treatment recommendations. Please plan accordingly and ensure you have sufficient privacy to comfortably participate in this portion of your appointment.
Without an appropriate anatomical assessment, Erica may be unable to provide individualized treatment recommendations or accurate cost estimates. If the assessment cannot be completed during your scheduled consultation, an additional appointment may be required, which may involve an additional consultation fee.
Our goal is to make your consultation as comfortable, informative, and productive as possible while ensuring you receive an accurate, personalized evaluation.
Yes. All consultations are scheduled appointments dedicated to providing individualized medical guidance and professional recommendations.
Our consultation options include:
Your consultation fee covers the dedicated time, clinical expertise, individualized assessment, patient education, and professional recommendations provided by Erica Granteed, AGACNP-BC.
Consultations are medical appointments, not simply conversations about pricing or services. Each appointment involves a personalized evaluation to determine whether a treatment is medically appropriate, safe, and aligned with your goals and realistic expectations.
All consultation fees are collected at the time of scheduling and are non-refundable. The fee compensates the provider for her time and professional expertise, regardless of whether you ultimately choose to proceed with treatment or are determined to be an appropriate candidate.
Please note: Payment for a consultation does not guarantee treatment eligibility, approval for a specific procedure, or any particular outcome. All treatment recommendations are based on clinical judgment, patient safety, and individual medical considerations.
Wonderful! Simply contact our office and let our team know you’re ready to move forward or utilize our online booking link to schedule ScroTox.
We will review appointment availability, discuss any required scheduling fees, and coordinate your treatment appointment with Erica Granteed, AGACNP-BC.
Depending on your treatment plan, additional instructions, documentation, or pre-treatment requirements may be necessary. Our team will guide you through the process to ensure you’re fully prepared.
Not at all! We regularly welcome patients who travel from across the United States and internationally to receive treatment at The District Injector.
For patients traveling from outside the Northern Virginia area, we offer the convenience of beginning with a virtual consultation through our secure, HIPAA-compliant patient platform. This allows you to meet privately with Erica Granteed, AGACNP-BC, to discuss your medical history, concerns, treatment goals, and potential candidacy without the expense or inconvenience of traveling for an initial appointment.
Please keep in mind that virtual consultations may require a brief visual assessment of your anatomy to determine treatment eligibility and provide individualized recommendations and cost estimates.
Once you have completed your consultation and decide to move forward with treatment, our team will assist with coordinating your appointment and provide a travel brochure featuring helpful information about nearby airports, transportation, accommodations, and local hotel options.
For certain procedures, including male enhancement with HA filler, we recommend that patients remain in the local area for at least 48 hours following treatment. This allows time for initial recovery and provides an opportunity to address any immediate post-procedure concerns before traveling home.
Depending on your treatment and individual circumstances, follow-up appointments may also be conducted virtually.
Our goal is to make traveling for treatment as convenient, comfortable, and well-coordinated as possible while prioritizing your safety and continuity of care.
The District Injector
8180 Greensboro Drive, Suite 300
McLean, VA 22102
Our office is located on the third floor, and the parking garage elevator provides direct access to our floor.
Parking Options:
The District Injector is located in McLean, Virginia, and operates exclusively on Eastern Time (ET). All appointments, including virtual consultations, are scheduled according to our local time zone, regardless of where the patient resides or is physically located at the time of their appointment.
It is each patient’s responsibility to verify the time difference between their location and Eastern Time when scheduling an appointment. We strongly encourage patients traveling or joining virtually from other states or countries to confirm the correct appointment time in their respective time zones.
Please note: Misunderstanding, overlooking, or failing to account for time zone differences does not qualify as an exception to our scheduling, cancellation, or no-show policies. Appointments missed due to time zone confusion are considered missed appointments, and consultation fees will not be refunded, credited, or transferred for this reason.
We appreciate your understanding and encourage you to double-check your appointment confirmation to ensure you are available at the correct scheduled time.
Absolutely! We welcome patients from across the United States and beyond.
Many of our patients travel specifically for Erica’s experience in men’s aesthetic and sexual wellness treatments.
To make the process as convenient as possible, we offer virtual consultations for eligible patients and provide travel resources once a treatment plan has been established.
Our team is happy to help you understand the logistics of traveling for your procedure, including any recommended post-treatment observation or follow-up requirements.
Absolutely. At The District Injector, we understand that discussing personal, intimate, or sensitive health concerns requires a high level of trust, privacy, and discretion. We are committed to providing a professional, respectful, and judgment-free environment where every patient feels comfortable discussing their concerns openly and honestly.
All consultations, examinations, and treatments are conducted with the utmost professionalism and respect for your personal privacy. Your medical information, treatment history, photographs, and personal details are handled confidentially in accordance with applicable HIPAA privacy and security regulations.
We utilize secure patient communication systems and electronic medical records to safeguard your protected health information. Patient photographs, medical records, and treatment details are never shared publicly or used for marketing purposes without appropriate written authorization.
Whether you’re seeking treatment for aesthetic concerns, sexual wellness, or other personal health matters, you can expect the same level of discretion, professionalism, and individualized attention.
Your privacy matters to us, and our goal is to ensure you feel respected, comfortable, and confident throughout every step of your care.
Initial pricing for ScroTox starts at $1,200 for 100 units
There is currently insufficient clinical research to determine whether ScroTox affects male fertility. While ScroTox is primarily used for cosmetic purposes to relax the scrotal muscles and create a smoother, lower-hanging appearance, its potential effects on sperm production and reproductive health have not been adequately studied.
The scrotum plays an important role in regulating testicular temperature, which is essential for healthy sperm production. Because ScroTox relaxes the dartos muscle and may alter the natural position and temperature regulation of the testicles, there are theoretical concerns regarding its potential impact on fertility.
Important Considerations:
If you are actively trying to conceive, we recommend postponing elective ScroTox treatment until your reproductive goals and potential risks have been thoroughly discussed with your healthcare provider.
At The District Injector, Erica Granteed, AGACNP-BC, evaluates each patient’s medical history, treatment goals, and reproductive considerations to determine whether ScroTox is an appropriate option.
Your reproductive health and long-term well-being will always take priority over cosmetic enhancement.
Your ScroTox appointment is designed to be comfortable, discreet, and efficient.
Upon arrival, clinical photographs will be taken for your confidential medical record to document your anatomy and establish a baseline for evaluating your results.
A topical numbing cream will then be applied to help minimize discomfort during treatment. Once the area is adequately numbed, the skin will be thoroughly cleansed and prepared for the procedure.
Erica Granteed, AGACNP-BC, will then carefully administer the ScroTox injections according to your individualized treatment plan.
You can expect to be in our office for approximately 45–60 minutes, including photography.
Our goal is to ensure you feel comfortable, informed, and confident throughout your entire treatment experience.
Most patients find ScroTox to be a quick, well-tolerated procedure with minimal discomfort. We take several steps to help make your treatment experience as comfortable as possible.
Before treatment, a topical numbing cream is applied to the scrotum to help minimize sensitivity at the injection sites. Once the area is adequately numbed, Erica Granteed, AGACNP-BC, will carefully administer the injections using a fine needle.
You may experience a brief pinch, mild stinging, or pressure during the injections. Because the scrotal skin is sensitive, discomfort can vary from person to person. Topical numbing helps reduce surface sensitivity but may not eliminate all sensations.
Following treatment, mild tenderness, redness, swelling, or bruising may occur at the injection sites. These effects are generally temporary and typically resolve within a few days.
Our priority is to make your ScroTox experience as comfortable, discreet, and stress-free as possible. Erica will explain each step of the procedure and ensure you feel informed and supported throughout your appointment.
Trimix is a prescription injectable medication used to treat erectile dysfunction (ED). It combines three medications—papaverine, phentolamine, and alprostadil—that work together to relax smooth muscle and increase blood flow into the penis, helping produce an erection.
Unlike oral erectile dysfunction medications, such as Viagra (sildenafil) or Cialis (tadalafil), Trimix is injected directly into the erectile tissue of the penis, allowing it to work locally rather than relying primarily on the body’s natural erectile response.
Trimix is commonly considered for men who have not achieved satisfactory results with oral medications, cannot tolerate them, or are seeking an alternative treatment.
Trimix contains three medications that work together to improve penile blood flow:
Together, these medications help the corpora cavernosa fill with blood, producing an erection.
Trimix is a compounded prescription medication and is not FDA-approved as a combination product. However, alprostadil is FDA-approved as an individual injectable treatment for erectile dysfunction.
Trimix is prescribed by qualified healthcare providers and prepared by licensed compounding pharmacies.
Trimix may be appropriate for men who:
Not everyone is an appropriate candidate. Erica Granteed, AGACNP-BC, will review your medical history, medications, cardiovascular health, and treatment goals before determining whether Trimix is appropriate.
Trimix is not a penile enlargement treatment. Its purpose is to help achieve an erection by increasing blood flow into the erectile tissue.
For men who have difficulty achieving a full erection, Trimix may help restore their natural erect size by allowing the erectile tissue to fill more completely.
Trimix does not permanently increase penile length or girth.
Yes. Every Trimix treatment program begins with an initial consultation with Erica Granteed, AGACNP-BC.
During your consultation, Erica Granteed, AGACNP-BC, will review your medical history, erectile concerns, current medications, previous ED treatments, and overall sexual health.
She will also evaluate whether Trimix is medically appropriate, explain the treatment process, and discuss realistic expectations, potential side effects, and safety precautions.
If Trimix is appropriate, your prescription will be ordered through a licensed compounding pharmacy.
Trimix is not administered or dispensed during your initial consultation.
Our Trimix treatment process is designed to ensure that patients receive an individualized dose and understand how to administer their medication safely.
Step 1: Initial Consultation
Your first appointment is a private consultation with Erica Granteed, AGACNP-BC, to review your medical history, erectile dysfunction concerns, previous treatments, and candidacy for Trimix.
Step 2: Medication Ordering
Once Erica Granteed, AGACNP-BC, determines that Trimix is appropriate, your medication will be prescribed and ordered through a licensed compounding pharmacy.
The medication must be available for your scheduled injection training appointment.
Step 3: In-Office Dosing Assessment
You will return to our office for a supervised Trimix injection. Erica Granteed, AGACNP-BC, will administer an initial dose and monitor your response to assess the medication’s effectiveness, erection quality, duration, and tolerability.
The goal is to identify the lowest effective dose that produces a satisfactory erection while minimizing the risk of complications.
Additional supervised dose adjustments or visits may be necessary.
Step 4: Self-Injection Education
During your appointment, Erica Granteed, AGACNP-BC, will provide detailed education on proper medication preparation, injection technique, injection site selection, safe needle handling, storage, dosing, and recognizing potential complications.
You will have the opportunity to ask questions and demonstrate your understanding before beginning independent treatment.
Step 5: Taking Your Medication Home
Once your response has been appropriately assessed, your dosing instructions have been established, and Erica Granteed, AGACNP-BC, determines that you can safely administer the medication independently, you may leave with your prescribed medication, provided it has been dispensed to you in accordance with applicable pharmacy and dispensing requirements.
You will receive instructions regarding safe use, storage, and follow-up care.
Trimix dosing is highly individualized. The amount of medication required to achieve a satisfactory erection can vary significantly between patients.
An in-office injection allows Erica Granteed, AGACNP-BC, to evaluate how your body responds to the medication before you begin administering it independently.
This appointment helps determine an appropriate starting dose, assess effectiveness, identify potential side effects, and reduce the risk of prolonged erections.
It also ensures that you receive hands-on education rather than attempting your first injection without professional guidance.
For eligible patients, the initial consultation may be completed virtually.
However, your initial Trimix injection and dosing assessment must be performed in person at The District Injector.
This allows Erica Granteed, AGACNP-BC, to evaluate your response, monitor for complications, and provide the necessary hands-on injection training.
No. Trimix requires a separate medication ordering and supervised dosing process.
Your initial consultation is dedicated to evaluating your candidacy, discussing treatment options, and establishing a plan.
If treatment is appropriate, your medication will be ordered, and you will return for a separate in-office dosing and education appointment.
Not necessarily. While the initial supervised injection provides valuable information about your response, some patients require additional dose adjustments to achieve the desired result safely.
Never increase your Trimix dose independently or repeat an injection during the same session unless specifically directed by your prescribing provider.
Trimix typically begins working within 5–20 minutes after injection.
Response time can vary depending on the medication concentration, prescribed dose, injection technique, and individual physiology.
The goal is to achieve an erection sufficient for sexual activity without causing an excessively prolonged erection.
Many patients experience erections lasting approximately 30–60 minutes, although individual responses vary.
An erection that lasts longer than intended may require medical evaluation.
An erection lasting 4 hours or longer is a medical emergency and requires immediate evaluation in an emergency department. Do not wait for the office to open or for a message response.
Yes. Unlike oral ED medications, Trimix can produce an erection without sexual stimulation because it acts directly on penile erectile tissue.
Sexual stimulation may still contribute to the overall experience but is not necessarily required for the medication to work.
Trimix may be effective for some patients who have not achieved satisfactory results with oral erectile dysfunction medications.
Because Trimix works directly within the erectile tissue, it may produce an erection even when oral medications have been unsuccessful.
However, effectiveness varies, and treatment success cannot be guaranteed.
No. Trimix is designed to improve erectile function, not sexual desire.
It does not directly increase testosterone, libido, or sexual arousal.
Patients experiencing decreased sexual desire may benefit from a separate evaluation for hormonal, psychological, medication-related, or other contributing factors.
Trimix may improve erection firmness and rigidity in patients with erectile dysfunction.
The goal is to achieve an erection that is sufficiently firm for sexual activity while using the lowest effective medication dose.
Some patients may notice changes in their response over time due to progression of underlying erectile dysfunction, changes in overall health, medication storage or potency, or other factors.
If your usual dose becomes less effective, contact our office for reassessment.
Do not independently increase your dose.
Trimix is injected into one of the two corpora cavernosa, the erectile chambers located along the shaft of the penis.
During your training appointment, Erica Granteed, AGACNP-BC, will demonstrate the appropriate injection location and technique.
Proper injection placement is essential to achieving the intended effect and minimizing complications.
Most patients describe the injection as a brief pinch or mild stinging sensation.
Trimix is administered using a small, fine needle, and many patients find that injections become easier with appropriate education and experience.
Some patients may experience discomfort from the medication itself, particularly formulations containing alprostadil.
Absolutely. Hands-on injection education is an essential part of our Trimix treatment process.
During your in-office appointment, Erica Granteed, AGACNP-BC, will review:
You should feel comfortable with the process and demonstrate an understanding of safe administration before beginning treatment at home.
Trimix should only be used according to your individualized prescription instructions.
A commonly recommended limit is no more than one injection within 24 hours and no more than three injections per week, although your provider may establish a more restrictive schedule.
Frequent injections can increase the risk of bruising, scarring, and other complications.
No. Never administer an additional injection during the same treatment session to compensate for an inadequate response unless specifically instructed by your provider.
Repeating injections can significantly increase the risk of priapism, a prolonged erection that can permanently damage erectile tissue.
Contact our office to discuss an appropriate dosing reassessment.
Do not combine Trimix with sildenafil (Viagra), tadalafil (Cialis), or other erectile dysfunction medications unless specifically instructed by your prescribing provider.
Combining these medications may increase the risk of excessive blood pressure reduction, prolonged erections, and priapism.
Trimix is generally temperature-sensitive and may require refrigeration or freezing depending on the specific formulation.
Always follow the storage instructions provided by your compounding pharmacy.
Improper storage can reduce medication effectiveness. Do not use medication that has expired or has been stored outside the pharmacy’s recommended conditions without first consulting your pharmacist.
Yes, although special precautions may be necessary to maintain the medication’s required storage temperature.
Patients should transport Trimix according to their pharmacy’s instructions and avoid exposing it to excessive heat.
When traveling by air, keep the medication in its labeled prescription packaging and review applicable airline and security requirements.
Potential side effects include:
More serious complications include priapism, which requires immediate medical attention.
Priapism is a prolonged erection that persists beyond the intended duration and can occur independently of sexual stimulation.
It is one of the most important risks associated with penile injection therapy.
An erection lasting 4 hours or longer is a medical emergency.
Untreated ischemic priapism can permanently damage erectile tissue and result in long-term erectile dysfunction.
If an erection remains unusually firm or persists longer than expected, follow your provider’s written emergency instructions and seek prompt medical guidance. Do not wait until the four-hour mark to begin seeking help.
If an erection reaches four hours, go directly to an emergency department.
When used appropriately, Trimix can be an effective treatment option. However, incorrect dosing, improper injection technique, repeated injections, or untreated complications can cause lasting injury.
Potential long-term complications include penile fibrosis, curvature, and erectile tissue damage associated with prolonged erections.
This is why we require supervised dosing and injection education before independent administration.
Repeated penile injections may contribute to scar tissue formation, which can sometimes lead to penile curvature or worsen an existing curvature.
Proper injection technique, rotating injection sites, and following the prescribed treatment schedule help reduce this risk.
Patients with existing Peyronie’s disease or penile fibrosis require individualized assessment before treatment.
No. Trimix may not be appropriate for patients with certain medical conditions, including a history of recurrent priapism, some blood disorders, significant penile scarring, or other conditions that increase treatment risks.
Patients taking anticoagulants or medications affecting blood pressure may require additional precautions.
Erica Granteed, AGACNP-BC, will review your medical history and medications to determine whether treatment is appropriate.
Trimix is not intended to alter sperm production, testosterone levels, or fertility.
There is no established evidence that properly administered Trimix directly impairs sperm production. However, research on reproductive outcomes is limited, and serious complications involving erectile tissue could affect sexual function.
Patients with fertility concerns should discuss them during their consultation.
Trimix pricing varies depending on the prescribed formulation, concentration, quantity, and dispensing pharmacy. The average cost is $100.
Your treatment may involve separate costs for:
Medication pricing will be discussed once the appropriate prescription has been determined.
No. The initial consultation is a separate medical appointment that covers Erica Granteed, AGACNP-BC’s dedicated time, clinical evaluation, patient education, and individualized treatment recommendations.
Our initial 30-minute consultation fee is $300.
Medication, in-office dosing, injection training, and any additional appointments may involve separate fees.
The District Injector is a self-pay medical practice and does not accept insurance.
Some patients may have pharmacy benefits that apply to certain erectile dysfunction medications, but coverage varies by plan and pharmacy.
Patients are responsible for confirming any potential coverage or reimbursement directly with their insurance provider.
Follow-up appointments may be recommended to assess treatment effectiveness, review your dosing, evaluate side effects, and determine whether adjustments are necessary.
Some patients may require additional supervised dosing appointments before a safe and effective home regimen can be established.
Refills are determined by Erica Granteed, AGACNP-BC, based on your treatment response, medical history, and ongoing monitoring needs.
Additional evaluation may be required before refills are authorized.
Prescription refills are not automatic and should be requested in advance to allow adequate processing time.
That’s completely understandable! Many patients feel apprehensive about penile injections initially.
Our in-office education appointment is specifically designed to help you become familiar with the medication, understand the injection process, and develop confidence in safe self-administration.
Erica Granteed, AGACNP-BC, will explain the process, answer your questions, and assess your readiness before you begin treatment independently.
You will not be expected to administer injections at home without appropriate instruction.
Getting started with Trimix at The District Injector is simple.
First, schedule your initial consultation with Erica Granteed, AGACNP-BC. If Trimix is appropriate for you, your medication will be ordered, and our team will coordinate your return appointment for supervised dosing and self-injection education.
Once your response has been assessed and you have demonstrated safe administration, you may begin using your prescribed medication at home according to your individualized treatment plan.
Simply contact our office and let our team know you’re ready to move forward or utilize our online booking link to schedule.
We will review appointment availability, discuss any required scheduling fees, and coordinate your treatment appointment with Erica Granteed, AGACNP-BC.
Depending on your treatment plan, additional instructions, documentation, or pre-treatment requirements may be necessary. Our team will guide you through the process to ensure you’re fully prepared.
A penile Doppler ultrasound is a specialized diagnostic examination used to evaluate blood flow within the penis and assess the vascular factors that may contribute to erectile dysfunction (ED).
The examination uses ultrasound technology to visualize penile structures and measure blood flow through the penile arteries. When performed with an intracavernosal injection (ICI), it also allows the provider to evaluate how blood enters and is retained within the erectile tissue during an induced erection.
At The District Injector, Erica Granteed, AGACNP-BC, performs penile Doppler ultrasound evaluations to help identify potential vascular contributors to erectile dysfunction and guide individualized treatment recommendations.
A penile Doppler ultrasound may help identify or evaluate:
The examination provides important diagnostic information, but findings must be interpreted alongside your medical history, symptoms, physical examination, and other relevant testing.
A standard ultrasound produces images of anatomical structures.
A Doppler ultrasound also evaluates the movement of blood through vessels, allowing the provider to measure blood flow velocity and direction.
A penile Doppler ultrasound can assess both penile anatomy and vascular function, particularly when performed following medication-induced erection.
A penile Doppler ultrasound may be recommended if you:
Not every patient with erectile dysfunction requires a penile Doppler ultrasound. Erica Granteed, AGACNP-BC, will determine whether the examination is appropriate based on your symptoms and medical history.
It can help identify whether abnormal penile blood flow may be contributing to your erectile dysfunction.
However, erectile dysfunction can result from multiple factors, including vascular disease, neurological conditions, hormonal abnormalities, medication effects, psychological factors, and underlying medical conditions.
A penile Doppler ultrasound focuses primarily on penile anatomy and vascular function. It does not evaluate every possible cause of erectile dysfunction.
Yes. An initial consultation is required before undergoing a penile Doppler ultrasound at The District Injector unless you have a referral from your Urologist.
During your consultation, Erica Granteed, AGACNP-BC, will review your medical history, erectile concerns, current medications, previous treatments, and relevant risk factors.
The consultation helps determine whether penile Doppler imaging is medically appropriate and whether an intracavernosal injection will be necessary for a complete vascular assessment.
If an injection-assisted examination is recommended, the appropriate medication and testing arrangements will be coordinated before your procedure.
Before your appointment, all patients are required to register through our Symplast Patient App and complete their Medical History Questionnaire and all required consent forms at least 72 hours prior to their scheduled appointment. This allows Erica Granteed, AGACNP-BC, adequate time to thoroughly review your medical history, assess relevant information, and prepare for your consultation.
Failure to complete the required documentation within the designated timeframe may result in cancellation of your appointment and forfeiture of your consultation fee.
We also ask that you arrive on time and fully prepared for your appointment. Time spent completing outstanding paperwork or arriving late will not extend your scheduled appointment. Your consultation will still conclude at its originally scheduled time, regardless of when you are ready to begin.
We respect every patient’s time and are committed to maintaining our appointment schedule. Extending one appointment would delay care for the patients scheduled afterward, which is why we are unable to accommodate additional time for late arrivals or incomplete paperwork.
We appreciate your cooperation in completing all requirements in advance so that your entire appointment can be dedicated to addressing your concerns, discussing your goals, and providing the personalized care you deserve.
Your appointment generally includes the following steps:
Step 1: Medical Review and Preparation
Erica Granteed, AGACNP-BC, will review your relevant medical history, medications, allergies, and any changes since your initial consultation.
The examination process, potential risks, and expected findings will be discussed before proceeding.
Step 2: Baseline Ultrasound Evaluation
Ultrasound gel is applied to the penis, and a handheld ultrasound transducer is used to examine penile structures and assess baseline blood flow.
Step 3: Intracavernosal Injection (When Indicated)
For a comprehensive erectile vascular assessment, a medication may be injected directly into the corpus cavernosum, the erectile tissue within the penis.
This medication helps relax penile smooth muscle and increase blood flow, producing an erection for diagnostic evaluation.
Step 4: Doppler Blood Flow Measurements
As the medication takes effect, Erica Granteed, AGACNP-BC, will obtain ultrasound measurements at appropriate intervals to assess arterial blood flow and erectile hemodynamics.
Measurements may include peak systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI).
Step 5: Monitoring and Recovery
Following the examination, your erectile response will be monitored.
Because medication-induced erections can occasionally last longer than intended, additional observation or treatment may be necessary before you leave.
Step 6: Results and Treatment Planning
Your findings will be reviewed and interpreted in the context of your symptoms and overall health.
Erica Granteed, AGACNP-BC, will discuss appropriate next steps, which may include additional testing, medical management, or referral to another specialist.
Not every penile ultrasound requires an injection.
However, when the goal is to evaluate erectile blood flow and distinguish potential arterial insufficiency from veno-occlusive dysfunction, an intracavernosal injection is commonly necessary.
The medication produces an erectile response that allows blood flow to be evaluated under conditions more representative of an erection.
Without adequate erectile response, certain vascular findings may be incomplete or misleading.
An intracavernosal medication, such as alprostadil or an appropriate compounded formulation, may be used to stimulate an erection.
The medication and dose are selected based on your medical history, prior response to erectile dysfunction medications, and individual risk factors.
The medication is administered by Erica Granteed, AGACNP-BC, as part of the diagnostic examination.
The injection technique may be similar to that used for Trimix therapy, but the medication administered during a penile Doppler examination is intended to produce an erectile response for diagnostic testing.
Depending on the clinical circumstances, the medication may be alprostadil or another appropriate intracavernosal formulation.
The diagnostic dose is individualized and should not be assumed to be the same as a patient’s usual home injection dose.
The ultrasound examination and associated monitoring commonly require approximately 60–90 minutes, although the total appointment time may vary.
Additional observation may be necessary depending on your response to the injected medication.
Patients should allow flexibility in their schedule because medication-induced erections do not always resolve within a predictable timeframe.
You will receive individualized preparation instructions before your examination.
These may include reviewing your current medications, avoiding certain erectile dysfunction treatments for a specified period when medically appropriate, and informing our office of any changes in your health.
Do not stop prescribed medications unless instructed by your healthcare provider.
Certain erectile dysfunction medications may affect your response to the examination or increase the risk of a prolonged erection when combined with intracavernosal medications.
Erica Granteed, AGACNP-BC, will provide specific instructions regarding sildenafil (Viagra), tadalafil (Cialis), and other erectile dysfunction medications before your appointment.
The appropriate withholding period depends on the medication, dose, and your medical history.
Please inform our office if you currently use Trimix, Bimix, or another intracavernosal injection therapy.
Your medication history and usual response are important when determining an appropriate diagnostic injection dose and reducing the risk of prolonged erections.
Do not administer your usual penile injection before the examination unless specifically instructed to do so.
You may typically eat and drink normally before your appointment.
Specific restrictions are not universally required. If abstinence or other preparation is necessary for your examination, our office will provide instructions in advance.
No. Shaving is generally not required for a penile Doppler ultrasound.
Comfortable clothing is recommended.
You may wish to wear supportive underwear because temporary penile sensitivity or a lingering erectile response can occur after the examination.
The ultrasound portion is generally painless.
You may feel mild pressure as the transducer moves along the penis.
If an intracavernosal injection is administered, you may experience a brief pinch, mild stinging, or temporary discomfort.
Some medications may also cause penile aching during the erection.
Yes, an erection is typically expected during an injection-assisted penile Doppler ultrasound.
The purpose of the medication is to create an erectile response so that blood flow can be evaluated.
The degree of firmness varies between patients.
An incomplete erectile response does not automatically mean you have severe vascular disease. Anxiety, medication response, dosing, and other factors can influence the findings.
Not every patient develops a fully rigid erection during the examination.
If your response is inadequate, Erica Granteed, AGACNP-BC, will determine whether the available measurements are interpretable and whether further assessment is appropriate.
Inadequate smooth muscle relaxation can sometimes produce Doppler findings that resemble venous leak, even when true veno-occlusive dysfunction has not been established.
Sexual stimulation is not necessarily required because the injected medication acts directly on the erectile tissue.
However, some diagnostic protocols may incorporate appropriate stimulation to help achieve a more complete erectile response.
Any such measures should be discussed beforehand and performed only with your informed consent.
The penis must be accessible for accurate ultrasound imaging.
Your privacy and comfort are priorities throughout the appointment. Appropriate draping will be used when possible, and only the areas necessary for the examination will be exposed.
Absolutely.
At The District Injector, sexual health concerns are addressed professionally, respectfully, and discreetly.
Your medical history, examination findings, and diagnostic information are handled as confidential medical information in accordance with applicable privacy requirements.
Peak systolic velocity, or PSV, measures the maximum speed of blood flowing through the penile arteries during the systolic phase of the cardiac cycle.
It is an important measurement used to assess arterial blood supply to the penis.
Commonly referenced interpretive ranges include:
These ranges are not absolute. Interpretation depends on the examination technique, timing, medication response, and clinical context.
End-diastolic velocity, or EDV, measures blood flow within the penile arteries during the diastolic phase of the cardiac cycle.
As a normal erection develops, pressure within the erectile tissue increases and diastolic arterial flow generally decreases.
Persistently elevated EDV during an adequately rigid, medication-induced erection may suggest veno-occlusive dysfunction.
An EDV above approximately 5 cm/s is commonly used as a concerning finding, but it is not diagnostic by itself.
The resistive index is a calculation based on systolic and diastolic blood flow velocities.
It is calculated as:
RI = (PSV − EDV) ÷ PSV
The RI provides additional information about vascular resistance during the erectile response.
A lower-than-expected RI may support concern for veno-occlusive dysfunction, although it must be interpreted with the other measurements and the quality of the erection.
Arterial insufficiency occurs when the arteries supplying the penis cannot deliver sufficient blood flow to support an adequate erection.
Potential contributing factors include:
Penile Doppler ultrasound can help identify findings consistent with reduced arterial inflow.
The term venous leak is commonly used to describe corporal veno-occlusive dysfunction.
During a normal erection, the erectile chambers fill with blood and compress the veins responsible for draining blood from the penis.
This helps maintain the pressure needed for a firm erection.
When this mechanism does not function adequately, blood may leave the erectile tissue too readily, making it difficult to maintain rigidity.
A penile Doppler ultrasound can identify findings suggestive of veno-occlusive dysfunction, but an inadequate medication-induced erection can create misleading results.
A penile Doppler ultrasound can provide evidence supporting suspected veno-occlusive dysfunction.
However, a single abnormal Doppler measurement does not always establish a definitive diagnosis.
Adequate smooth muscle relaxation and erectile response are essential for reliable interpretation.
Additional testing or specialist evaluation may be recommended when results are inconclusive or when invasive treatment is being considered.
Yes. Ultrasound may identify plaques, calcifications, and other structural changes associated with Peyronie’s disease.
When an erection is induced, the examination may also help assess penile curvature and related deformities.
However, diagnosis and treatment planning may require additional clinical assessment.
No. A penile Doppler ultrasound primarily evaluates penile anatomy and blood flow.
It does not directly measure nerve function.
If a neurological cause of erectile dysfunction is suspected, additional evaluation may be necessary.
Normal penile blood flow does not rule out erectile dysfunction.
Other contributing factors may include hormonal imbalances, medication effects, neurological conditions, performance anxiety, psychological factors, or other medical concerns.
Erica Granteed, AGACNP-BC, will discuss whether additional evaluation or treatment is appropriate.
Penile ultrasound itself is noninvasive and does not use ionizing radiation.
When an intracavernosal injection is used, the examination carries additional risks related to the medication and injection.
These include temporary discomfort, bruising, bleeding, prolonged erection, and, rarely, more serious complications.
Potential side effects of an injection-assisted penile Doppler ultrasound include:
The risks will be discussed before the examination.
Priapism is a prolonged erection that can occur after intracavernosal injection therapy.
A prolonged erection can interfere with normal oxygen delivery to erectile tissue and may cause permanent damage if not treated promptly.
An erection lasting four hours or longer is a medical emergency.
If your erection remains unusually firm or persists longer than expected, follow the emergency instructions provided by your clinician and seek prompt medical guidance.
If an erection reaches four hours, proceed directly to an emergency department. Do not wait for a return call or for the office to reopen.
Your erectile response will be monitored following the examination.
If the erection remains excessively firm or prolonged, additional treatment may be necessary.
Depending on the circumstances, this may include medication to reverse the erection or emergency medical evaluation.
Patients should not leave with a persistent, concerning erection without appropriate clinical assessment and instructions.
Many patients can drive themselves home after the examination.
However, if you experience dizziness, medication-related symptoms, a prolonged erection, or require additional treatment, driving may not be appropriate.
Erica Granteed, AGACNP-BC, will provide individualized guidance based on your response.
You may be advised to avoid sexual activity or additional erectile dysfunction medications for a period following the examination, particularly if you received an intracavernosal injection.
Resume sexual activity only after the medication-induced erection has fully resolved and you have followed your provider’s post-procedure instructions.
If the findings suggest arterial insufficiency, Erica Granteed, AGACNP-BC, will review the results and discuss appropriate treatment options.
Depending on your medical history and the severity of your symptoms, recommendations may include:
Penile arterial insufficiency can sometimes be associated with broader cardiovascular disease, so additional medical evaluation may be important.
If the findings suggest veno-occlusive dysfunction, treatment recommendations will depend on the severity of your symptoms, erectile response, and overall clinical picture.
Possible options may include oral medications, intracavernosal injections, vacuum erection devices, or referral to a urologist for additional evaluation and treatment.
Not every patient with suspected veno-occlusive dysfunction requires surgery.
Not necessarily.
A penile Doppler ultrasound is a diagnostic examination, and its purpose is to provide information that can help guide treatment.
If Trimix is appropriate, Erica Granteed, AGACNP-BC, may recommend a separate treatment program involving medication prescribing, supervised dose assessment, and self-injection education.
A diagnostic injection administered during your ultrasound does not automatically establish your home Trimix dose or replace the required training process.
A penile Doppler ultrasound does not measure testosterone levels or diagnose hormonal deficiencies.
If your symptoms suggest a possible hormonal contribution to erectile dysfunction, laboratory testing may be recommended.
Preliminary findings may be discussed during your appointment.
A complete interpretation requires review of the blood flow measurements, erectile response, medical history, and examination findings.
Additional discussion or follow-up may be necessary to establish an individualized treatment plan.
Yes, when medically appropriate.
Repeat testing may be considered if an initial examination was inconclusive, the erectile response was inadequate, symptoms have changed, or additional information is needed for treatment planning.
Routine repeat examinations are not necessary for every patient.
The cost of a penile Doppler ultrasound is $350. The District Injector will provide applicable pricing information before scheduling your diagnostic procedure.
Your initial consultation, diagnostic examination, medication, and any additional follow-up services may involve separate charges.
Yes. All penile Doppler evaluations begin with an initial consultation unless a referral is provided from your Urologist.
The initial 30-minute consultation fee is $300.
This consultation allows Erica Granteed, AGACNP-BC, to review your medical history, assess your concerns, and determine whether the diagnostic examination is appropriate.
The consultation fee is separate from the cost of the ultrasound examination and any associated medications.
The District Injector is a self-pay medical practice and does not accept insurance.
Patients are responsible for the cost of their consultation, diagnostic testing, and any additional services.
Some patients may be able to use Health Savings Account (HSA) or Flexible Spending Account (FSA) funds for eligible medical services.
Eligibility and reimbursement are determined by your individual plan administrator and cannot be guaranteed by The District Injector.
Penile Doppler ultrasound evaluations are performed at:
The District Injector
8180 Greensboro Drive, Suite 300
McLean, VA 22102
Our office provides a private, professional environment for men’s sexual health consultations and examinations.
Simply contact our office and let our team know you’re ready to move forward or utilize our online booking link to schedule Penile Doppler Ultrasound.
We will review appointment availability, discuss any required scheduling fees, and coordinate your treatment appointment with Erica Granteed, AGACNP-BC.
Depending on your treatment plan, additional instructions, documentation, or pre-treatment requirements may be necessary. Our team will guide you through the process to ensure you’re fully prepared.
Piezo shockwave therapy is a noninvasive treatment that uses focused acoustic pressure waves to stimulate biological responses within targeted tissues.
In men’s sexual health, low-intensity extracorporeal shockwave therapy (Li-ESWT) has been studied as a potential treatment for certain types of erectile dysfunction (ED), particularly erectile dysfunction associated with impaired penile blood flow.
At The District Injector, Erica Granteed, AGACNP-BC, offers individualized shockwave therapy using piezoelectric technology to address selected men’s sexual health concerns.
Unlike medications that temporarily assist with achieving an erection, shockwave therapy is being investigated for its potential to improve aspects of erectile function over time.
However, treatment outcomes vary, and shockwave therapy is not a guaranteed or permanent cure for erectile dysfunction.
"Piezo" refers to piezoelectric technology, which uses specialized crystals or ceramic elements that respond to electrical energy by producing mechanical pressure waves.
These waves can be focused toward a selected treatment area.
Piezoelectric shockwave technology differs from radial pressure-wave devices and other acoustic technologies in how energy is generated and delivered.
Piezoelectric shockwave therapy delivers acoustic pressure waves into targeted tissue.
Research suggests that low-intensity shockwaves may influence several biological processes, including:
These mechanisms are still being studied, particularly in relation to erectile dysfunction.
The goal is to potentially improve erectile function rather than simply produce a temporary medication-induced erection.
Not necessarily.
Although the terms are sometimes used interchangeably, different devices deliver different forms of mechanical energy.
Focused shockwave therapy directs acoustic energy toward a defined treatment region.
Radial pressure-wave therapy produces pressure waves that spread outward from the applicator and have different physical characteristics.
Clinical outcomes reported for one technology should not automatically be assumed to apply to another.
There is currently no FDA-cleared or FDA-approved low-intensity shockwave device specifically indicated to treat erectile dysfunction.
Although shockwave technology is used in several areas of medicine, its use for erectile dysfunction remains investigational in the United States.
Some international clinical guidelines recognize low-intensity shockwave therapy as a possible option for selected men with vascular erectile dysfunction, while other professional organizations recommend limiting its use to research settings.
Patients should understand the limitations of the available evidence before proceeding.
No.
Piezo shockwave therapy is noninvasive and does not require surgical incisions, stitches, or anesthesia in most cases.
Treatment is performed in the office using a handheld applicator.
No.
Shockwave therapy uses mechanical acoustic energy rather than ionizing radiation.
Potentially, yes.
Clinical studies of low-intensity shockwave therapy suggest that some men experience modest improvements in erectile function, particularly those with mild to moderate vasculogenic erectile dysfunction.
However, studies vary in their treatment protocols, devices, patient populations, and outcomes.
Not every patient experiences improvement, and results cannot be guaranteed.
Vasculogenic erectile dysfunction occurs when abnormalities in blood vessel function interfere with achieving or maintaining an erection.
Potential contributing factors include:
Because shockwave therapy is primarily being studied for its potential vascular effects, patients with this type of erectile dysfunction may be considered for treatment.
Some clinical studies have reported improvements in penile blood flow or erectile function following low-intensity shockwave treatment.
However, findings are not consistent across all studies.
Improved penile circulation is a potential treatment goal, but it cannot be guaranteed.
Some patients report improved erection firmness and rigidity following treatment.
The degree of improvement depends on the underlying cause of erectile dysfunction, severity of symptoms, overall health, and individual response.
Patients with severe erectile dysfunction may experience less benefit than those with mild vascular impairment.
It may improve erection maintenance in some patients with vascular erectile dysfunction.
However, shockwave therapy does not directly treat premature ejaculation or guarantee longer sexual activity.
Some patients may experience sufficient improvement to reduce their reliance on oral erectile dysfunction medications.
Others may continue to require sildenafil (Viagra), tadalafil (Cialis), or another treatment.
Do not discontinue prescribed erectile dysfunction medications without discussing the change with your healthcare provider.
In many cases, yes.
Oral erectile dysfunction medications may be continued during shockwave therapy when medically appropriate.
Erica Granteed, AGACNP-BC, will review your medication regimen and determine whether any adjustments are necessary.
Some patients who have experienced limited success with oral erectile dysfunction medications may be considered for shockwave therapy.
However, treatment is not guaranteed to restore responsiveness to oral medications.
Patients with severe vascular disease, neurological injury, or advanced erectile dysfunction may require other treatment options.
Diabetes can affect erectile function through changes in blood vessels, nerves, and metabolic health.
Shockwave therapy has been studied in men with diabetes-related erectile dysfunction, but results are variable.
Controlling blood glucose, managing cardiovascular risk factors, and addressing other contributing conditions remain essential.
Low-intensity shockwave therapy has been investigated as a possible component of penile rehabilitation following radical prostatectomy.
However, evidence is insufficient to establish it as a standard treatment for post-prostatectomy erectile dysfunction.
Patients with erectile dysfunction following prostate surgery may benefit from a comprehensive evaluation and discussion of established treatment options.
The term venous leak generally refers to corporal veno-occlusive dysfunction, in which the penis has difficulty maintaining the pressure required for a firm erection.
Shockwave therapy has not been established as an effective treatment for correcting structural veno-occlusive dysfunction.
If a venous leak is suspected, Erica Granteed, AGACNP-BC, may recommend additional evaluation, including a penile Doppler ultrasound, to better understand the underlying cause.
Some patients with mild vascular erectile dysfunction may experience improvement.
However, shockwave therapy cannot reliably reverse advanced arterial disease or significant vascular obstruction.
A penile Doppler ultrasound may be recommended when a more detailed vascular assessment is appropriate.
Peyronie’s disease is a condition involving the development of fibrous scar tissue, or plaques, within the tunica albuginea surrounding the erectile chambers of the penis.
This can cause:
Symptoms and severity vary significantly between patients.
Shockwave therapy has been studied as a treatment for Peyronie’s disease, particularly for reducing penile pain.
Some studies suggest that extracorporeal shockwave therapy may improve pain associated with Peyronie’s disease.
However, shockwave therapy has not consistently demonstrated meaningful improvements in penile curvature or plaque size.
It should not be presented as a treatment that reliably straightens the penis.
No reliable clinical evidence demonstrates that low-intensity shockwave therapy consistently breaks apart or eliminates Peyronie’s plaques.
Although shockwaves are used for other medical purposes, such as certain forms of stone fragmentation, penile shockwave treatment does not work in the same way.
Patients should not expect shockwave therapy to dissolve scar tissue.
Shockwave therapy is not an established treatment for correcting penile curvature caused by Peyronie’s disease.
Clinical studies have not consistently shown meaningful improvements in curvature.
Patients seeking correction of penile curvature may require evaluation for other treatments, such as penile traction therapy, selected intralesional injections, or surgical intervention.
Some studies suggest that shockwave therapy may reduce pain associated with Peyronie’s disease.
However, pain associated with Peyronie’s disease can also improve naturally over time, making it difficult to determine how much improvement is directly attributable to treatment.
Current clinical guidelines generally do not recommend shockwave therapy for reducing penile curvature or plaque size. Some recognize a possible role in pain management.
There is insufficient evidence to conclude that shockwave therapy prevents Peyronie’s disease progression.
Patients experiencing new or worsening curvature, pain, penile shortening, or deformity should undergo appropriate clinical evaluation.
There is no reliable evidence that shockwave therapy restores penile length lost due to Peyronie’s disease.
Other treatment options, including appropriately prescribed penile traction therapy, may be considered depending on the patient’s condition and goals.
In selected patients, shockwave therapy and penile traction therapy may be discussed as separate components of a broader treatment plan.
However, there is insufficient evidence that combining them provides additional benefit beyond established Peyronie’s treatments.
Erica Granteed, AGACNP-BC, will review your diagnosis, symptoms, and treatment goals before making recommendations.
Possibly.
Some patients have both conditions, and the appropriate treatment depends on whether erectile dysfunction, pain, curvature, or another concern is the primary problem.
Shockwave therapy may be considered for selected erectile dysfunction concerns, but it should not be expected to correct Peyronie’s-related curvature.
A comprehensive evaluation helps determine the most appropriate treatment plan.
No. Shockwave therapy is not a proven penile enlargement treatment.
It has not been demonstrated to permanently increase penile length or girth.
Patients who experience improved erection quality may notice that their penis reaches its natural erect dimensions more consistently.
However, this should not be confused with actual tissue enlargement.
Shockwave therapy has not been established as a reliable treatment for increasing flaccid penile hang.
Changes in flaccid appearance may occur for various reasons, including temperature, circulation, smooth muscle tone, and individual anatomy.
No.
Shockwave therapy is not a testosterone replacement treatment and has not been demonstrated to reliably increase testosterone production.
Patients experiencing symptoms of low testosterone may benefit from a separate hormonal evaluation.
Shockwave therapy does not directly increase sexual desire.
Some patients may experience improved sexual confidence if their erectile function improves, but this is different from a direct effect on libido.
Shockwave therapy is not an established treatment for premature ejaculation.
Patients experiencing premature ejaculation may benefit from evaluation for other treatment options.
There is insufficient evidence that penile shockwave therapy directly improves orgasm intensity, ejaculation volume, or ejaculatory function.
Shockwave therapy is not an established fertility treatment.
It has not been demonstrated to reliably improve sperm production, sperm quality, or male reproductive outcomes.
Shockwave therapy is not an established treatment for penile sensory loss or numbness.
Penile numbness may be related to neurological, vascular, medication-related, or other medical conditions and should be evaluated appropriately.
Depending on your medical history and goals, shockwave therapy may be considered alongside other treatments, including:
Combining treatments does not necessarily improve outcomes, and some combinations have limited supporting evidence.
Erica Granteed, AGACNP-BC, will determine whether combination therapy is appropriate.
Yes. All shockwave therapy treatment plans begin with an initial consultation with Erica Granteed, AGACNP-BC.
During this appointment, your medical history, sexual health concerns, previous treatments, current medications, and treatment goals will be reviewed.
The consultation is intended to determine whether shockwave therapy is appropriate and whether additional diagnostic testing may be beneficial.
Your consultation may include discussion of:
Additional testing may be recommended when appropriate.
Not every patient requires laboratory testing specifically for shockwave therapy.
However, bloodwork may be recommended when erectile dysfunction could be associated with hormonal, metabolic, or cardiovascular conditions.
Testing may include testosterone levels, blood glucose markers, lipid levels, or other relevant laboratory studies.
Not necessarily.
A penile Doppler ultrasound may be recommended when additional information about penile arterial blood flow or suspected veno-occlusive dysfunction would help guide treatment decisions.
The need for diagnostic imaging is determined individually.
Treatment generally involves the following steps:
Step 1: Preparation
You will be positioned comfortably in a private treatment room.
The treatment area will be exposed as necessary, and ultrasound or coupling gel may be applied to help transmit acoustic energy.
Step 2: Treatment Application
Erica Granteed, AGACNP-BC, will position the piezoelectric shockwave applicator over selected treatment areas.
Acoustic pulses are delivered according to the treatment protocol.
Step 3: Completion
Once the prescribed treatment has been completed, the gel is removed, and the treatment area is assessed as appropriate.
Step 4: Aftercare
You will receive any necessary post-treatment instructions and information regarding your next appointment.
For erectile dysfunction treatment, acoustic energy may be directed toward selected areas along the penile shaft and the proximal erectile tissues, depending on the device and protocol.
For Peyronie’s-related pain, the treatment approach may differ.
The treatment locations are determined by your clinical evaluation and the specific equipment being used.
No.
Shockwave therapy is generally performed while the penis is flaccid.
An erection is not required for the acoustic waves to be delivered.
No.
Shockwave therapy itself does not require penile injections.
However, injections may be used separately for diagnostic testing or other erectile dysfunction treatments when clinically appropriate.
At The District Injector, shockwave therapy appointments are generally scheduled for approximately 30 minutes.
The actual time during which acoustic pulses are delivered may be shorter.
Shockwave therapy is generally performed as a series of treatments rather than a single session.
Published erectile dysfunction studies have used different protocols, commonly involving approximately 6–12 sessions over several weeks.
However, there is no universally established treatment schedule, and the appropriate number of sessions depends on the specific device, clinical indication, and treatment plan.
Erica Granteed, AGACNP-BC, will discuss your recommended treatment schedule during your consultation.
A single session is not generally considered a complete course of shockwave therapy for erectile dysfunction.
Most clinical studies have evaluated multiple sessions.
A single treatment should not be expected to produce a reliable or lasting improvement.
Additional treatments may be considered following reassessment.
However, more sessions do not necessarily produce better results.
The benefits, costs, and uncertainties of additional treatment should be reviewed before proceeding.
Most patients tolerate low-intensity shockwave therapy without significant discomfort.
You may feel tapping, pulsing, or pressure sensations as the applicator delivers acoustic energy.
Some areas may be more sensitive than others.
If treatment becomes uncomfortable, notify your provider.
Anesthesia is generally not required for low-intensity penile shockwave therapy.
Comfort measures can be discussed if necessary.
Most patients can return to their normal daily activities immediately after treatment.
However, individual recommendations may vary depending on the treatment area, symptoms, and any other procedures performed.
Many patients can resume sexual activity as tolerated following uncomplicated low-intensity shockwave treatment.
If you experience tenderness, discomfort, or other symptoms, you may be advised to temporarily avoid sexual activity.
Follow the specific instructions provided by Erica Granteed, AGACNP-BC.
Most patients can resume routine activities following treatment.
If you experience discomfort, temporary modification of activities may be recommended.
Low-intensity shockwave therapy is generally well tolerated.
Temporary redness, tenderness, or mild discomfort may occur.
Significant bruising or swelling is not expected with properly administered low-intensity treatment and should be reported for evaluation.
Aftercare recommendations may include:
Specific instructions will be provided based on your treatment plan.
Shockwave therapy does not typically produce an immediate erection or immediate improvement in erectile function.
Some patients report changes during their treatment series, while others notice improvement in the weeks following completion.
Clinical studies commonly assess outcomes several weeks to months after treatment.
The duration of improvement varies.
Some studies have reported benefits lasting several months or longer in selected patients, while other patients experience limited or temporary improvement.
Long-term durability remains uncertain.
No. Shockwave therapy should not be considered a permanent cure for erectile dysfunction.
Erectile dysfunction may be influenced by aging, vascular disease, diabetes, medications, and other health conditions that can change over time.
Even patients who initially improve may experience recurrent symptoms.
No.
Some patients experience meaningful improvement, others notice modest changes, and some experience no improvement.
Response is influenced by the underlying cause and severity of erectile dysfunction, overall health, treatment protocol, and other factors.
If you do not experience improvement, Erica Granteed, AGACNP-BC, may recommend reassessing the underlying causes of your erectile dysfunction.
Additional diagnostic testing or alternative treatment options may be appropriate.
Continuing shockwave therapy indefinitely without meaningful benefit is not recommended.
There is currently no universally established maintenance schedule for penile shockwave therapy.
Some treatment programs offer repeat sessions, but the ideal timing and long-term benefit of maintenance therapy have not been clearly established.
Any recommendation for additional treatment should be based on your response and clinical circumstances.
Low-intensity shockwave therapy has generally demonstrated a favorable short-term safety profile in published erectile dysfunction studies.
Reported adverse effects are usually mild and temporary.
However, long-term safety data remain limited, and findings from one device or treatment protocol cannot automatically be applied to every other system.
Potential side effects may include:
Unexpected or persistent symptoms should be reported to your healthcare provider.
When appropriate low-intensity treatment protocols are used, serious tissue injury has been uncommon in published studies.
However, the risk depends on the equipment, energy settings, treatment location, and individual medical circumstances.
Improper use or inappropriate energy delivery may increase the risk of tissue injury.
There is no established evidence that appropriately delivered low-intensity penile shockwave therapy routinely causes erectile dysfunction.
However, long-term data are limited, and treatment should be performed only after appropriate clinical assessment.
Clinical studies have not consistently demonstrated worsening of Peyronie’s disease from appropriately administered shockwave treatment.
However, treatment does not reliably prevent disease progression.
Patients experiencing worsening curvature, pain, or penile deformity should be reassessed.
Shockwave therapy may not be appropriate for patients with certain medical conditions or treatment-area concerns.
These may include:
Patients taking anticoagulants or those with implanted medical devices should disclose this information before treatment.
Eligibility is determined individually.
Possibly, depending on the medication, the treatment protocol, and your individual bleeding risk.
Anticoagulant and antiplatelet medications may increase the risk of bruising or bleeding.
Do not discontinue prescribed blood thinners without authorization from the clinician managing that medication.
Patients who have undergone penile girth enhancement with hyaluronic acid filler should disclose their treatment history before shockwave therapy.
The presence of filler may affect treatment planning and the suitability of certain application sites.
There is limited clinical evidence regarding the effects of penile shockwave therapy on previously placed HA filler.
Erica Granteed, AGACNP-BC, will assess your treatment history, anatomy, and healing status before determining whether shockwave therapy is appropriate.
Patients who use Trimix injections may still be candidates for shockwave therapy.
However, shockwave therapy does not replace proper Trimix dosing, injection training, or medication monitoring.
Your existing erectile dysfunction treatment regimen will be reviewed during your consultation.
Patients with penile prostheses require individualized evaluation.
The safety and effectiveness of applying shockwave energy around penile implants have not been adequately established.
Treatment should not proceed without consideration of the implant type, manufacturer’s guidance, and appropriate specialist recommendations.
At The District Injector, shockwave therapy is $400 per session.
The total cost of treatment depends on the number of sessions recommended.
Additional consultation, diagnostic testing, or other medical services may involve separate fees.
Yes. An initial consultation is required before beginning shockwave therapy.
Your consultation allows Erica Granteed, AGACNP-BC, to review your symptoms, medical history, previous treatments, and goals to determine whether shockwave therapy is an appropriate option.
The initial 30-minute consultation fee is $300.
This fee covers the medical evaluation, discussion of treatment options, and individualized recommendations.
The consultation fee is separate from shockwave treatment costs.
The District Injector is a self-pay medical practice and does not accept insurance.
Shockwave therapy for erectile dysfunction is generally considered investigational by many insurers and may not be covered.
Patients are responsible for the cost of treatment.
Some patients may be eligible to use HSA or FSA funds for certain medical services.
However, eligibility and reimbursement depend on your plan’s requirements and cannot be guaranteed.
Depending on your individual medical needs, Erica Granteed, AGACNP-BC, may discuss additional men’s sexual health services, including:
Treatment recommendations are based on your clinical findings rather than a one-size-fits-all approach.
The best way to determine whether you are an appropriate candidate is to schedule a consultation.
Erica Granteed, AGACNP-BC, will review your concerns, evaluate potential contributing factors, and explain the benefits, limitations, risks, and alternatives.
Not every patient will benefit from shockwave therapy, and treatment will only be recommended when clinically appropriate.
The first step is to schedule an initial consultation with Erica Granteed, AGACNP-BC.
During your consultation, we will review your erectile dysfunction symptoms, Peyronie’s disease concerns, or other sexual health goals and determine whether piezo shockwave therapy is an appropriate option.
If treatment is recommended, our team will coordinate your treatment appointments and provide any necessary preparation instructions.
Schedule Your Consultation:
https://scheduling.symplast.com/thedistrictinjector/1
The District Injector
8180 Greensboro Drive, Suite 300
McLean, VA 22102
Phone/Text: 202-800-0612
Website: www.TheDistrictInjector.com
Your sexual health deserves individualized care, realistic expectations, and treatment recommendations grounded in clinical evaluation.
Dominate Your Life.
Piezoelectric shockwave therapy for erectile dysfunction is an investigational treatment in the United States. There is currently no FDA-cleared or FDA-approved low-intensity shockwave device specifically indicated for erectile dysfunction.
Although some clinical studies report improvements in erectile function among selected patients, results vary, and the ideal treatment protocol, long-term effectiveness, and durability remain uncertain.
For Peyronie’s disease, extracorporeal shockwave therapy may help reduce pain in some patients but has not consistently demonstrated meaningful improvements in penile curvature or plaque size.
Treatment outcomes cannot be guaranteed. Shockwave therapy does not replace comprehensive evaluation of erectile dysfunction, cardiovascular risk factors, hormonal conditions, or other underlying medical concerns.
All treatment recommendations are individualized and determined by Erica Granteed, AGACNP-BC, following appropriate medical assessment.
EMSELLA is a noninvasive treatment designed to strengthen and rehabilitate the pelvic floor muscles using High-Intensity Focused Electromagnetic (HIFEM®) technology.
The treatment is performed while you sit fully clothed on a specialized chair that delivers electromagnetic stimulation to the pelvic floor muscles, producing repeated involuntary muscle contractions.
EMSELLA is FDA-cleared for the treatment of urinary incontinence in men and women through pelvic floor muscle rehabilitation and restoration of neuromuscular control.
At The District Injector, Erica Granteed, AGACNP-BC, evaluates patients interested in pelvic floor health, urinary control, and sexual wellness to determine whether EMSELLA is appropriate for their individual needs.
EMSELLA uses electromagnetic energy to stimulate the pelvic floor muscles, producing thousands of contractions during a treatment session.
These contractions help activate and retrain muscles involved in bladder control and pelvic floor support.
The treatment is designed to improve pelvic floor muscle function without requiring patients to perform voluntary contractions throughout the session.
The pelvic floor is a group of muscles located at the bottom of the pelvis.
These muscles help support the bladder, bowel, and other pelvic structures and contribute to:
Weakness, poor coordination, or excessive tension within these muscles can contribute to pelvic health symptoms.
EMSELLA and Kegel exercises both involve the pelvic floor muscles, but they work differently.
Kegel exercises require you to voluntarily contract and relax your pelvic floor muscles.
EMSELLA uses electromagnetic energy to generate involuntary contractions, allowing the muscles to be stimulated without the patient repeatedly performing Kegels.
However, EMSELLA does not necessarily replace pelvic floor physical therapy or a structured exercise program.
EMSELLA is FDA-cleared, rather than FDA-approved, for its intended use in rehabilitation of weak pelvic floor muscles and restoration of neuromuscular control for the treatment of male and female urinary incontinence.
Its use specifically to improve sexual performance, erectile dysfunction, or orgasm quality is not an FDA-cleared indication in the United States.
No. EMSELLA is completely noninvasive.
There are no surgical incisions, needles, injections, or internal devices used during the treatment.
Patients remain fully clothed throughout their session.
Yes. EMSELLA can be used in both men and women.
For men, pelvic floor muscle rehabilitation may be particularly relevant when urinary leakage or reduced pelvic floor muscle control is present.
The pelvic floor also contributes to erectile and ejaculatory function, although EMSELLA’s effectiveness for specific male sexual dysfunctions is less established than its role in urinary incontinence.
Possibly, in selected patients.
The pelvic floor muscles, particularly the bulbospongiosus and ischiocavernosus muscles, contribute to erectile rigidity and blood retention during an erection.
Pelvic floor muscle rehabilitation has shown benefits for some men with erectile dysfunction.
However, evidence specifically demonstrating that EMSELLA reliably treats erectile dysfunction remains limited.
EMSELLA should not be considered a replacement for established erectile dysfunction treatments.
Improved pelvic floor muscle function may support the muscular mechanisms involved in maintaining erectile rigidity.
However, improvement in erection firmness following EMSELLA cannot be guaranteed.
Patients experiencing erectile dysfunction may require additional evaluation for vascular, hormonal, neurological, or medication-related causes.
The pelvic floor muscles play a role in supporting erection maintenance.
Strengthening weak pelvic floor muscles may be beneficial for some men, but there is insufficient evidence to guarantee that EMSELLA improves erection duration.
Pelvic floor muscle training and rehabilitation may help selected men improve awareness and control of the muscles involved in ejaculation.
However, evidence specifically supporting EMSELLA as a treatment for premature ejaculation is limited.
Patients experiencing premature ejaculation should undergo an individualized assessment to identify appropriate treatment options.
Pelvic floor muscle contractions contribute to orgasm and ejaculation.
Some preliminary research has explored whether electromagnetic pelvic floor stimulation may improve aspects of sexual function.
However, EMSELLA is not an established treatment for increasing orgasm intensity, and results cannot be guaranteed.
No. EMSELLA does not increase penile length or girth.
It is a pelvic floor muscle rehabilitation treatment, not a penile enlargement procedure.
No. EMSELLA is not a hormonal treatment and has not been demonstrated to increase testosterone production.
EMSELLA does not directly increase sexual desire.
Although improvements in urinary control or pelvic floor confidence may positively affect quality of life, decreased libido may require evaluation for hormonal, psychological, medication-related, or other medical factors.
EMSELLA may be considered for selected men experiencing urinary leakage after prostate surgery.
However, post-prostatectomy urinary incontinence requires individualized evaluation, and evidence for EMSELLA in this population remains developing.
Pelvic floor muscle training is an established component of rehabilitation for many patients following prostate surgery.
EMSELLA should not replace appropriate urologic follow-up or recommended pelvic floor rehabilitation.
EMSELLA does not treat Peyronie’s plaques or reliably correct penile curvature.
It may be considered for a separate pelvic floor concern, but it is not an established treatment for Peyronie’s disease.
Not necessarily.
Some pelvic pain conditions involve excessive pelvic floor muscle tension rather than weakness.
In these situations, repeated strengthening contractions may be inappropriate or aggravate symptoms.
Patients with chronic pelvic pain, painful ejaculation, or suspected pelvic floor hypertonicity should undergo evaluation before considering EMSELLA.
Yes. Urinary incontinence is the primary intended treatment indication for EMSELLA.
The device stimulates pelvic floor muscles to help rehabilitate weakness and improve neuromuscular control.
Some patients experience improvements in urinary leakage and bladder control following a treatment series.
Results vary based on the type and severity of incontinence and other contributing medical conditions.
Stress urinary incontinence occurs when urine leaks during activities that increase pressure within the abdomen.
Examples include:
Weak pelvic floor support may contribute to this type of leakage.
EMSELLA may improve stress urinary incontinence symptoms in selected patients by stimulating and rehabilitating weak pelvic floor muscles.
However, the degree of improvement varies, and treatment may not eliminate leakage completely.
Urge urinary incontinence involves a sudden, strong urge to urinate followed by involuntary urine leakage.
It may be associated with overactive bladder or other medical conditions.
Some patients with urgency-related urinary symptoms may experience improvement following pelvic floor rehabilitation.
However, overactive bladder can have several contributing causes, and EMSELLA is not a guaranteed treatment.
Bladder training, behavioral modifications, medication, and other therapies may also be appropriate.
Mixed urinary incontinence involves both stress-related leakage and urgency-related leakage.
Treatment recommendations depend on which symptoms are most bothersome and the underlying contributing factors.
EMSELLA may be beneficial when urinary frequency is associated with pelvic floor dysfunction.
However, frequent urination can also result from urinary tract infections, diabetes, prostate enlargement, medication effects, or other conditions.
A medical evaluation may be necessary before treatment.
EMSELLA does not shrink the prostate or remove a urinary obstruction.
Men with benign prostatic hyperplasia (BPH) may experience urinary symptoms caused by obstruction, bladder dysfunction, or other factors.
A proper evaluation is important before assuming pelvic floor strengthening will address these symptoms.
It may be considered for selected patients with post-prostatectomy urinary leakage.
However, outcomes vary, and the evidence for EMSELLA specifically is less established than evidence for conventional pelvic floor muscle rehabilitation.
Some patients experience reduced urinary leakage and may use fewer protective pads following treatment.
However, complete elimination of leakage cannot be guaranteed.
Yes. All EMSELLA treatment plans at The District Injector begin with an initial consultation with Erica Granteed, AGACNP-BC.
During your consultation, your medical history, symptoms, medications, implanted devices, and treatment goals will be reviewed.
The purpose of the consultation is to determine whether EMSELLA is appropriate and whether additional evaluation is necessary.
Your consultation may include discussion of:
Additional testing or referral may be recommended depending on your symptoms.
Step 1: Preparation
You will be seated on the EMSELLA treatment chair while remaining fully clothed.
Step 2: Positioning
Your position will be adjusted to allow the electromagnetic field to appropriately target the pelvic floor muscles.
Step 3: Treatment
The device delivers electromagnetic stimulation that produces repeated pelvic floor muscle contractions.
You may experience tingling, pulsing, or a sensation similar to an intense pelvic floor workout.
Step 4: Completion
Once the session is complete, you may generally return to your normal activities immediately.
No. One of the benefits of EMSELLA is that treatment is performed while you remain fully clothed.
Comfortable, loose-fitting clothing is recommended.
An EMSELLA treatment session lasts approximately 28 minutes.
Your total appointment time may be slightly longer to allow for preparation and positioning.
A commonly recommended initial treatment series consists of six sessions, typically performed twice weekly over approximately three weeks.
The number of sessions may vary depending on your symptoms, treatment response, and individualized plan.
Additional treatments may be considered based on your response and ongoing symptoms.
However, more sessions do not automatically guarantee better results.
EMSELLA is generally delivered as a treatment series rather than a single appointment.
A single session may produce noticeable muscle contractions, but it should not be expected to provide the same results as a complete treatment course.
No. The EMSELLA device produces pelvic floor muscle contractions without requiring you to voluntarily perform Kegels.
For patients with pelvic floor weakness, a properly prescribed home exercise program may complement treatment.
However, Kegel exercises are not appropriate for every pelvic floor condition, particularly when excessive muscle tension is present.
Erica Granteed, AGACNP-BC, can discuss whether additional pelvic floor exercises or referral to a pelvic floor physical therapist would be beneficial.
EMSELLA is generally well tolerated.
Most patients describe a tingling, pulsing, or strong muscle contraction sensation in the pelvic floor.
Treatment should not cause significant pain.
If you experience discomfort, notify your provider immediately so the treatment can be adjusted or stopped.
No. EMSELLA does not typically require anesthesia or numbing medication.
No downtime is generally required.
Most patients can return to work, exercise, and other normal daily activities immediately after treatment.
Most patients can resume normal physical activity following treatment.
If you experience muscle soreness or discomfort, temporary activity modification may be appropriate.
Most patients can resume sexual activity as tolerated following an uncomplicated treatment session.
If you experience pelvic discomfort, allow symptoms to resolve and follow your provider’s recommendations.
Some patients may experience temporary pelvic floor muscle fatigue, mild soreness, or discomfort.
These symptoms are generally short-lived.
Persistent or worsening pain should be reported.
Normal hydration is recommended.
There is no established requirement to consume unusually large amounts of water specifically because of EMSELLA treatment.
Yes. Most patients can drive themselves home immediately following treatment.
Some patients notice changes in urinary control during their initial treatment series.
Others may experience improvement over the weeks following completion.
The timing and degree of improvement vary.
The duration of improvement varies depending on the underlying condition, pelvic floor health, and other factors.
Some patients maintain improvements for several months, while others may experience recurring symptoms.
Long-term durability remains an area of ongoing research.
No. EMSELLA should not be considered a permanent cure for urinary incontinence or pelvic floor dysfunction.
Pelvic floor muscle function can change with aging, medical conditions, pregnancy, surgery, and other factors.
Some patients may benefit from additional treatment following their initial series.
However, there is no universally established maintenance schedule.
Any additional treatment should be based on your symptoms, response, and clinical evaluation.
Not every patient responds to EMSELLA.
If you do not experience meaningful improvement, additional evaluation may be necessary to determine whether your symptoms are caused by pelvic floor weakness or another condition.
Alternative treatments may be more appropriate.
Yes, when clinically appropriate.
Pelvic floor physical therapy can provide individualized assessment of muscle strength, coordination, relaxation, and function.
EMSELLA may be considered as an adjunct for selected patients, but it does not replace the comprehensive evaluation and treatment provided by a pelvic floor physical therapist.
EMSELLA is generally well tolerated in appropriately selected patients.
However, the device generates a strong electromagnetic field, and certain medical conditions or implanted devices may make treatment inappropriate.
A medical screening is required before treatment.
Contraindications and precautions may include:
All implanted devices and relevant medical conditions must be disclosed before treatment.
Eligibility will be determined according to the manufacturer’s current safety instructions and your individual medical history.
No. Patients with cardiac pacemakers should not undergo EMSELLA treatment because of the potential for electromagnetic interference.
Metal implants may be a contraindication depending on their composition, location, and the manufacturer’s safety requirements.
Patients with orthopedic hardware, surgical implants, or other metallic devices must disclose this information before treatment.
Do not assume an implant is safe simply because it is located outside the pelvis.
A hip replacement requires specific review because it may contain metallic components near the treatment region.
Treatment should not proceed unless the implant has been evaluated against the device manufacturer’s contraindications and safety instructions.
Certain intrauterine devices, particularly those containing metal, may be contraindicated.
The type of IUD and manufacturer’s safety instructions must be reviewed before treatment.
No. EMSELLA treatment is not recommended during pregnancy.
Patients with symptoms of a urinary tract infection should undergo appropriate evaluation and treatment before beginning or continuing EMSELLA.
Symptoms may include burning with urination, fever, pelvic discomfort, urinary urgency, or increased frequency.
Potentially.
Patients with excessively tight or poorly relaxing pelvic floor muscles may experience symptoms that are not improved by additional strengthening contractions.
This is why identifying the underlying type of pelvic floor dysfunction is important before treatment.
Potential side effects may include:
Significant pain or unexpected symptoms should be reported promptly.
EMSELLA pricing depends on the recommended treatment plan and number of sessions.
The District Injector will provide applicable treatment pricing during your consultation.
Your initial consultation and any additional diagnostic services may involve separate fees.
Yes. An initial consultation with Erica Granteed, AGACNP-BC, is required before beginning treatment.
The consultation is intended to review your medical history, identify potential contraindications, and determine whether EMSELLA is appropriate for your concerns.
The initial 30-minute consultation fee is $300.
This fee covers your medical evaluation, discussion of treatment options, and individualized recommendations.
The consultation fee is separate from EMSELLA treatment costs.
The District Injector is a self-pay medical practice and does not accept insurance.
Patients are responsible for treatment costs.
Insurance reimbursement, if available, depends on the patient’s individual plan and coverage requirements.
Some patients may be eligible to use HSA or FSA funds for qualifying medical services.
Eligibility and reimbursement are determined by the individual plan administrator and cannot be guaranteed.
The District Injector
8180 Greensboro Drive, Suite 300
McLean, VA 22102
The first step is to schedule an initial consultation with Erica Granteed, AGACNP-BC.
During your consultation, we will review your pelvic floor symptoms, bladder control concerns, sexual health goals, and medical history to determine whether EMSELLA is an appropriate treatment option.
If treatment is recommended, our team will coordinate your appointments and provide any necessary preparation instructions.
Schedule Your Consultation:
https://scheduling.symplast.com/thedistrictinjector/1
The District Injector
8180 Greensboro Drive, Suite 300
McLean, VA 22102
Phone/Text: 202-800-0612
Website: www.TheDistrictInjector.com
Pelvic floor health plays an important role in urinary control, physical comfort, and overall quality of life. Our goal is to provide individualized care and help you understand the treatment options available for your concerns.
Dominate Your Life.
EMSELLA is FDA-cleared for noninvasive electromagnetic stimulation of the pelvic floor musculature to rehabilitate weak pelvic muscles and restore neuromuscular control in the treatment of urinary incontinence in men and women.
Its use specifically for erectile dysfunction, premature ejaculation, orgasm enhancement, or other sexual performance concerns is not an FDA-cleared indication in the United States. Evidence supporting these additional applications remains limited.
Results vary, and treatment is not appropriate for every patient. Patients with implanted electronic or metallic devices, pregnancy, certain medical conditions, or other contraindications may not be eligible.
All treatment recommendations are based on individualized medical evaluation and the manufacturer’s applicable safety instructions.
The D-Shot is a combination injectable treatment offered at The District Injector that incorporates platelet-rich plasma (PRP) and botulinum toxin type A (neurotoxin) as part of an individualized approach to men’s sexual wellness.
PRP is prepared from a sample of your own blood and contains concentrated platelets and associated growth factors. Botulinum toxin is a neuromodulator that temporarily reduces muscle contraction by affecting nerve signaling.
Both components have been investigated for their potential applications in erectile function, although their use for erectile dysfunction remains experimental or investigational.
At The District Injector, Erica Granteed, AGACNP-BC, evaluates each patient’s medical history, erectile concerns, and treatment goals before determining whether the D-Shot is appropriate.
The D-Shot is The District Injector’s name for its combination treatment involving platelet-rich plasma and neurotoxin injections.
It is designed as an individualized men’s sexual wellness procedure rather than a penile enlargement treatment.
The D-Shot combines two different treatment approaches.
Platelet-Rich Plasma (PRP)
PRP contains platelets and growth factors derived from the patient’s own blood. These components are involved in normal tissue repair and cellular signaling.
Researchers are investigating whether PRP may influence processes associated with penile vascular and erectile tissue function.
However, PRP has not been established as an effective regenerative treatment for erectile dysfunction.
Botulinum Toxin Type A
Botulinum toxin temporarily inhibits acetylcholine release at nerve terminals.
When injected into selected penile tissues, it has been investigated for its potential effects on smooth muscle tone and erectile function.
Early studies have reported encouraging findings in some patients, but larger clinical trials are necessary to establish effectiveness, safety, and optimal dosing.
The combination of PRP and neurotoxin has not been established as superior to either component alone.
No. The D-Shot is not an FDA-approved treatment for erectile dysfunction.
Botulinum toxin products are FDA-approved for certain other medical and cosmetic indications, but penile injections for erectile dysfunction are off-label.
PRP injections for erectile dysfunction are considered experimental.
The combination of PRP and botulinum toxin has not received FDA approval for treating erectile dysfunction or improving sexual performance.
No.
The term P-Shot is commonly used to describe penile injections of platelet-rich plasma alone.
The D-Shot offered at The District Injector combines PRP with botulinum toxin type A.
Both approaches are being investigated for possible sexual health applications, and neither has been established as a standard treatment for erectile dysfunction.
The D-Shot is being explored for its potential role in men’s sexual wellness.
Areas of ongoing investigation include:
These are potential areas of research rather than guaranteed clinical benefits.
There is currently insufficient evidence to establish that the combined D-Shot procedure reliably improves these outcomes.
The individual components of the D-Shot have been studied for erectile dysfunction.
Some small studies have reported improvements in erectile function following PRP or penile botulinum toxin injections.
However, results remain preliminary, and there is insufficient evidence to establish the D-Shot combination as an effective treatment for erectile dysfunction.
Patients with erectile dysfunction should also be evaluated for established treatment options.
Improved erection firmness is one of the outcomes being investigated in studies of penile botulinum toxin and PRP.
Some patients in early studies have reported improvements, but these findings cannot be assumed to apply to every patient or to the combined D-Shot procedure.
Improved erection firmness cannot be guaranteed.
Researchers are investigating whether these treatments may influence erectile function, including the ability to maintain an erection.
However, there is insufficient evidence to establish that the D-Shot reliably improves erection duration.
Penile botulinum toxin has been investigated in patients who have not responded adequately to oral erectile dysfunction medications.
Some early studies have reported improvements, but evidence remains limited.
The D-Shot should not be considered a proven alternative to sildenafil (Viagra), tadalafil (Cialis), or established erectile dysfunction treatments.
Not reliably.
Trimix is a compounded intracavernosal medication used to produce erections through direct pharmacological effects on erectile tissue.
The D-Shot does not work in the same way and has not been established as an effective replacement for Trimix.
Patients currently using Trimix should not discontinue or change their medication regimen without discussing it with their prescribing provider.
No. The D-Shot is not a penile enlargement procedure.
Any temporary swelling following treatment should not be mistaken for permanent enlargement.
Penile botulinum toxin has been investigated for its potential effect on smooth muscle tone and flaccid penile appearance.
However, there is insufficient evidence to establish that the D-Shot reliably increases flaccid hang.
Results cannot be guaranteed.
No.
The D-Shot does not contain testosterone and has not been demonstrated to increase testosterone production.
Patients experiencing symptoms of testosterone deficiency may benefit from a separate hormonal evaluation.
The D-Shot does not directly treat low sexual desire.
Libido can be influenced by hormonal health, medications, psychological factors, relationship concerns, sleep, and other medical conditions.
A separate evaluation may be appropriate.
There is insufficient clinical evidence that the D-Shot improves orgasm intensity or quality. This has however been reported by patients.
The D-Shot is not an established treatment for premature ejaculation.
Patients experiencing premature ejaculation may benefit from evaluation for other treatment options.
The D-Shot has not been established as a treatment for Peyronie’s disease.
It has not been demonstrated to reliably reduce penile curvature, eliminate plaques, or restore lost penile length.
Patients with Peyronie’s disease should undergo an appropriate clinical evaluation.
Patients interested in the D-Shot may include men who:
Interest in the procedure does not automatically establish medical candidacy.
Because clinical evidence is limited, experimental treatments such as PRP for erectile dysfunction are recommended by major sexual medicine organizations to be conducted within appropriate research protocols.
For eligible patients, the initial consultation may be performed virtually.
However, the D-Shot procedure itself must be performed in person.
An in-person examination may also be required before treatment.
Because the PRP component is prepared from your own blood, your medical history and any conditions affecting blood or platelet function must be reviewed.
Diabetes can contribute to erectile dysfunction through vascular and neurological changes.
Patients with diabetes require individualized evaluation, particularly when blood glucose control, healing, or infection risk is a concern.
The D-Shot has not been established as an effective treatment for diabetes-related erectile dysfunction.
Blood-thinning medications may increase the risk of bruising or bleeding associated with injections and blood collection.
Certain medications may also affect platelet function.
Do not stop anticoagulant or antiplatelet medications without authorization from the healthcare provider managing them.
The procedure may be inappropriate for patients with certain conditions, including:
Treatment eligibility is determined individually.
The procedure involves several steps.
Step 1: Clinical Assessment
Erica Granteed, AGACNP-BC, will review your medical history, confirm your treatment plan, and address any questions before proceeding.
Clinical photographs may be obtained for your confidential medical record when appropriate.
Step 2: Blood Collection
A sample of your blood is collected for preparation of platelet-rich plasma.
Step 3: PRP Preparation
The blood sample is processed using a centrifuge to separate and concentrate the platelet-containing portion.
Step 4: Treatment Preparation
The penile treatment area is cleaned, and topical or local anesthetic may be used as appropriate.
Step 5: PRP and Neurotoxin Administration
The PRP and botulinum toxin components are administered according to the individualized treatment plan.
The injection locations and techniques depend on the intended treatment approach and clinical assessment.
Step 6: Post-Procedure Instructions
Following treatment, the area is assessed, and you will receive individualized aftercare instructions.
The appointment includes blood collection, PRP processing, treatment preparation, injections, and post-procedure education.
Patients should allow approximately 45–60 minutes, although the total appointment time may vary.
No. An erection is not generally required to administer PRP or penile neurotoxin injections.
If an erection occurs during the appointment, it can be managed professionally as part of routine clinical care.
Patients may experience discomfort during the blood draw and penile injections.
Topical numbing or additional local anesthetic may be used when appropriate.
You may feel a brief pinch, pressure, stinging, or temporary tenderness.
Individual pain tolerance varies, and the procedure cannot be guaranteed to be pain-free.
General anesthesia is not typically required.
Comfort measures may include topical anesthetic or local numbing medication when clinically appropriate.
Yes. The D-Shot is performed as an office-based procedure, and patients generally remain awake.
Absolutely.
The District Injector provides a professional and discreet environment for men’s sexual health services.
Medical records and clinical photographs are handled in accordance with applicable patient privacy requirements.
There is no established or predictable timeline for results from the combined D-Shot procedure.
Botulinum toxin effects generally develop over days to weeks in approved applications, but the onset and clinical significance of effects following penile injections are not well established.
PRP-related outcomes are also uncertain.
Patients should not expect an immediate improvement in erectile function.
The duration of any benefit from the combined procedure has not been established.
Although botulinum toxin effects are temporary, duration varies by application, dose, and individual response.
There is insufficient evidence to provide a reliable duration of benefit for the D-Shot.
No permanent benefit has been established.
The procedure should not be considered a permanent cure for erectile dysfunction or other sexual health concerns.
There is no validated treatment schedule for the combined D-Shot procedure.
Clinical studies of PRP and botulinum toxin have used different protocols, and no standardized combination regimen has been established.
Additional treatment should not be assumed necessary or beneficial without clinical reassessment.
No.
Some patients may experience no noticeable improvement.
Because evidence for the combined procedure is limited, reliable response rates cannot currently be provided.
If you do not experience improvement, additional evaluation may be appropriate.
Depending on your symptoms, Erica Granteed, AGACNP-BC, may discuss established erectile dysfunction treatments or further diagnostic testing.
Most patients can return to many routine activities following an uncomplicated office-based injection procedure.
However, temporary tenderness, swelling, or bruising may occur.
Specific activity restrictions will depend on your treatment and clinical response.
You should follow the individualized post-procedure instructions provided by Erica Granteed, AGACNP-BC.
A temporary period of sexual abstinence may be recommended to allow injection sites to recover.
Do not resume sexual activity until you have been cleared according to your aftercare instructions.
Strenuous exercise may need to be temporarily restricted following the procedure.
Your provider will give specific recommendations based on the treatment performed and your recovery.
Mild swelling, tenderness, or bruising can occur following penile injections.
These effects are often temporary.
Increasing pain, spreading redness, fever, significant swelling, or other concerning symptoms require prompt medical evaluation.
Most patients can drive themselves home following an uncomplicated procedure performed without sedation.
If additional medications or circumstances affect your ability to drive safely, alternative arrangements may be necessary.
Medication recommendations should be individualized.
Because PRP procedures involve platelets, some clinicians advise avoiding certain anti-inflammatory medications around treatment. However, the clinical importance of these restrictions for penile PRP is not well established.
Do not discontinue medically necessary medications without appropriate guidance.
The long-term safety of the combined D-Shot procedure has not been adequately established in clinical trials.
PRP and botulinum toxin have each been studied in penile applications, but evidence for their combined use remains limited.
Patients should understand that experimental treatments may involve risks that have not yet been fully characterized.
Potential side effects include:
Additional adverse effects may be associated with botulinum toxin.
Any penile injection carries some risk of local tissue injury, bleeding, inflammation, or scar formation.
Repeated injections may increase certain risks.
The effects of penile PRP and botulinum toxin injections on male fertility have not been adequately studied.
Patients who are actively trying to conceive or have fertility concerns should discuss these issues before considering treatment.
Yes. Botulinum toxin products carry warnings about the potential spread of toxin effects beyond the injection site.
Although uncommon, serious effects can include generalized muscle weakness, swallowing difficulties, or breathing problems.
These symptoms require immediate medical attention.
The D-Shot and hyaluronic acid penile girth enhancement are different procedures.
HA filler is intended to increase penile girth, while the D-Shot is an experimental combination of PRP and neurotoxin.
Patients who have undergone penile filler enhancement require assessment of their anatomy, filler placement, and healing status before considering additional penile injections.
Because the D-Shot already includes a botulinum toxin component, additional CockTox may result in overlapping neurotoxin treatment.
Any proposed combination must account for the total dose, injection locations, and relevant safety considerations.
Erica Granteed, AGACNP-BC, will determine whether additional treatment is appropriate.
Patients using Trimix must inform Erica Granteed, AGACNP-BC, before treatment.
The appropriate timing for resuming penile injections depends on healing, injection-site condition, and the patient’s treatment regimen.
Do not resume injections until you have followed your post-procedure instructions.
PRP, botulinum toxin, and shockwave therapy have each been investigated for erectile dysfunction.
However, there is insufficient evidence to establish that combining these approaches produces superior outcomes.
Combination treatment should not be assumed to provide additional benefit.
In many cases, patients receiving testosterone replacement therapy may continue their prescribed regimen.
However, your medications, laboratory findings, and overall medical history should be reviewed before treatment.
Do not change your hormone regimen without medical guidance.
The D-Shot at The District Injector is $1,800.
This includes the combination PRP and neurotoxin procedure as offered by the practice.
Additional consultations, diagnostic testing, or other services may involve separate fees.
The District Injector is a self-pay medical practice and does not accept insurance.
Because the D-Shot is experimental and not an FDA-approved treatment for erectile dysfunction, insurance coverage should not be expected.
Eligibility depends on your individual plan and applicable rules governing eligible medical expenses.
Coverage or reimbursement cannot be guaranteed.